Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Erythrocytes | 124 | 2024 | 589 | 28.550 |
Why?
|
Blood Preservation | 82 | 2024 | 263 | 20.470 |
Why?
|
Metabolomics | 80 | 2024 | 538 | 15.430 |
Why?
|
Metabolome | 47 | 2023 | 287 | 10.250 |
Why?
|
Proteomics | 69 | 2024 | 859 | 8.870 |
Why?
|
Erythrocyte Transfusion | 30 | 2023 | 187 | 7.350 |
Why?
|
Proteome | 29 | 2023 | 345 | 5.520 |
Why?
|
Glycolysis | 45 | 2023 | 224 | 5.220 |
Why?
|
Blood Donors | 21 | 2024 | 89 | 5.100 |
Why?
|
Shock, Hemorrhagic | 14 | 2023 | 193 | 5.100 |
Why?
|
Oxidative Stress | 39 | 2022 | 1093 | 5.010 |
Why?
|
Hemolysis | 22 | 2024 | 146 | 4.950 |
Why?
|
Anemia, Sickle Cell | 12 | 2023 | 217 | 4.060 |
Why?
|
Mass Spectrometry | 36 | 2020 | 645 | 3.780 |
Why?
|
Energy Metabolism | 27 | 2022 | 715 | 3.590 |
Why?
|
Blood Transfusion | 14 | 2023 | 277 | 3.490 |
Why?
|
Pentose Phosphate Pathway | 16 | 2023 | 46 | 3.130 |
Why?
|
Plasma | 9 | 2022 | 213 | 3.110 |
Why?
|
Humans | 359 | 2024 | 115587 | 2.940 |
Why?
|
Blood Proteins | 13 | 2020 | 238 | 2.810 |
Why?
|
Hypoxia | 19 | 2023 | 937 | 2.760 |
Why?
|
Glucosephosphate Dehydrogenase | 9 | 2022 | 37 | 2.710 |
Why?
|
Animals | 178 | 2024 | 32102 | 2.610 |
Why?
|
Blood Platelets | 15 | 2023 | 350 | 2.530 |
Why?
|
Transfusion Medicine | 5 | 2023 | 8 | 2.460 |
Why?
|
High-Throughput Screening Assays | 6 | 2021 | 124 | 2.250 |
Why?
|
Amino Acids | 16 | 2023 | 454 | 2.170 |
Why?
|
Membrane Lipids | 5 | 2021 | 87 | 2.110 |
Why?
|
Leukemia, Myeloid, Acute | 20 | 2023 | 538 | 2.090 |
Why?
|
Glucose | 20 | 2023 | 904 | 2.020 |
Why?
|
Blood Banks | 8 | 2021 | 40 | 2.010 |
Why?
|
Fatty Acids | 16 | 2024 | 386 | 1.970 |
Why?
|
Purines | 11 | 2023 | 159 | 1.960 |
Why?
|
Chromatography, High Pressure Liquid | 19 | 2020 | 477 | 1.940 |
Why?
|
Wounds and Injuries | 10 | 2020 | 725 | 1.870 |
Why?
|
Mice | 95 | 2024 | 15052 | 1.840 |
Why?
|
Kynurenine | 9 | 2024 | 80 | 1.780 |
Why?
|
Oxidation-Reduction | 29 | 2021 | 924 | 1.730 |
Why?
|
Platelet Transfusion | 4 | 2023 | 63 | 1.700 |
Why?
|
Glutathione | 18 | 2022 | 303 | 1.700 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 6 | 2023 | 13 | 1.660 |
Why?
|
Cellular Reprogramming | 8 | 2021 | 84 | 1.650 |
Why?
|
Meat | 5 | 2014 | 86 | 1.640 |
Why?
|
Male | 139 | 2024 | 55949 | 1.560 |
Why?
|
Biomarkers | 30 | 2023 | 3466 | 1.560 |
Why?
|
Altitude Sickness | 6 | 2020 | 152 | 1.550 |
Why?
|
Pneumonia, Viral | 4 | 2020 | 344 | 1.540 |
Why?
|
Coronavirus Infections | 4 | 2020 | 336 | 1.540 |
Why?
|
Carbon | 7 | 2023 | 159 | 1.480 |
Why?
|
Pandemics | 6 | 2023 | 1334 | 1.480 |
Why?
|
Cryopreservation | 7 | 2018 | 93 | 1.470 |
Why?
|
Pancreatic Neoplasms | 7 | 2023 | 722 | 1.470 |
Why?
|
Muscle, Skeletal | 15 | 2024 | 1447 | 1.450 |
Why?
|
Succinic Acid | 5 | 2020 | 43 | 1.410 |
Why?
|
Lymph | 5 | 2016 | 40 | 1.360 |
Why?
|
Blood Coagulation Disorders | 5 | 2023 | 196 | 1.330 |
Why?
|
Biochemistry | 4 | 2015 | 40 | 1.300 |
Why?
|
Mitochondria | 19 | 2022 | 750 | 1.290 |
Why?
|
Leukocyte Reduction Procedures | 6 | 2020 | 25 | 1.290 |
Why?
|
Female | 135 | 2023 | 59913 | 1.280 |
Why?
|
Adult | 90 | 2023 | 30718 | 1.270 |
Why?
|
Cattle | 11 | 2022 | 935 | 1.260 |
Why?
|
Erythrocyte Membrane | 7 | 2022 | 50 | 1.260 |
Why?
|
Oxygen | 16 | 2022 | 837 | 1.260 |
Why?
|
Sciuridae | 3 | 2020 | 142 | 1.250 |
Why?
|
Food Analysis | 3 | 2012 | 18 | 1.210 |
Why?
|
Muscle Proteins | 6 | 2019 | 209 | 1.180 |
Why?
|
Polyamines | 3 | 2022 | 39 | 1.170 |
Why?
|
Drug Discovery | 4 | 2013 | 124 | 1.150 |
Why?
|
Choline | 8 | 2022 | 108 | 1.130 |
Why?
|
Time Factors | 30 | 2021 | 6165 | 1.130 |
Why?
|
Lactic Acid | 7 | 2023 | 275 | 1.110 |
Why?
|
Isotope Labeling | 3 | 2017 | 76 | 1.110 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 3 | 2021 | 22 | 1.110 |
Why?
|
Interleukin-6 | 2 | 2020 | 677 | 1.100 |
Why?
|
Neoplastic Stem Cells | 11 | 2023 | 331 | 1.090 |
Why?
|
Aging | 14 | 2024 | 1631 | 1.080 |
Why?
|
Drug Resistance, Neoplasm | 10 | 2023 | 638 | 1.060 |
Why?
|
Hypertension, Pulmonary | 11 | 2023 | 1749 | 1.060 |
Why?
|
Liver | 16 | 2022 | 1690 | 1.060 |
Why?
|
Inflammation | 22 | 2024 | 2499 | 1.060 |
Why?
|
Adenine | 4 | 2022 | 221 | 1.050 |
Why?
|
Signal Transduction | 27 | 2023 | 4541 | 1.050 |
Why?
|
Renal Insufficiency, Chronic | 5 | 2023 | 488 | 1.040 |
Why?
|
Alzheimer Disease | 4 | 2023 | 438 | 1.020 |
Why?
|
Hematopoietic Stem Cells | 5 | 2023 | 346 | 1.020 |
Why?
|
Protein D-Aspartate-L-Isoaspartate Methyltransferase | 2 | 2023 | 5 | 1.020 |
Why?
|
Rh-Hr Blood-Group System | 2 | 2023 | 10 | 1.010 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2023 | 208 | 0.980 |
Why?
|
Altitude | 4 | 2023 | 409 | 0.950 |
Why?
|
Stearoyl-CoA Desaturase | 2 | 2021 | 53 | 0.940 |
Why?
|
Sodium Chloride | 3 | 2014 | 136 | 0.930 |
Why?
|
Blood Group Antigens | 1 | 2023 | 14 | 0.920 |
Why?
|
Adenosine Triphosphate | 13 | 2024 | 431 | 0.920 |
Why?
|
Hemoglobin SC Disease | 1 | 2023 | 15 | 0.910 |
Why?
|
Mice, Inbred C57BL | 34 | 2024 | 4773 | 0.910 |
Why?
|
Reactive Oxygen Species | 11 | 2022 | 549 | 0.900 |
Why?
|
Macrophages | 15 | 2023 | 1284 | 0.890 |
Why?
|
Hypocalcemia | 1 | 2023 | 31 | 0.880 |
Why?
|
Sickle Cell Trait | 1 | 2023 | 14 | 0.870 |
Why?
|
Disease Models, Animal | 24 | 2023 | 3580 | 0.870 |
Why?
|
Rejuvenation | 3 | 2022 | 14 | 0.860 |
Why?
|
Protein Processing, Post-Translational | 6 | 2021 | 401 | 0.860 |
Why?
|
Hibernation | 3 | 2020 | 72 | 0.860 |
Why?
|
Neoplasms | 9 | 2024 | 2118 | 0.860 |
Why?
|
Testosterone | 2 | 2023 | 337 | 0.850 |
Why?
|
Cell Line, Tumor | 27 | 2023 | 2751 | 0.850 |
Why?
|
Citric Acid Cycle | 7 | 2021 | 42 | 0.840 |
Why?
|
Athletic Performance | 1 | 2023 | 42 | 0.840 |
Why?
|
Tryptophan | 6 | 2021 | 136 | 0.840 |
Why?
|
Equidae | 1 | 2022 | 4 | 0.840 |
Why?
|
Organ Preservation Solutions | 9 | 2014 | 42 | 0.830 |
Why?
|
Tumor Suppressor Proteins | 3 | 2020 | 286 | 0.830 |
Why?
|
Renal Insufficiency | 2 | 2022 | 137 | 0.810 |
Why?
|
Erythropoietin | 1 | 2022 | 72 | 0.810 |
Why?
|
Drosophila Proteins | 5 | 2024 | 159 | 0.800 |
Why?
|
Glycerophospholipids | 1 | 2022 | 29 | 0.800 |
Why?
|
beta-Thalassemia | 4 | 2023 | 23 | 0.800 |
Why?
|
Healthy Volunteers | 9 | 2022 | 192 | 0.800 |
Why?
|
Isoaspartic Acid | 1 | 2021 | 3 | 0.800 |
Why?
|
Adaptation, Physiological | 5 | 2018 | 476 | 0.790 |
Why?
|
Carnitine | 5 | 2022 | 61 | 0.790 |
Why?
|
Pyruvate Kinase | 5 | 2023 | 20 | 0.780 |
Why?
|
Zika Virus | 1 | 2022 | 61 | 0.770 |
Why?
|
Xanthine | 2 | 2020 | 7 | 0.760 |
Why?
|
Diethylhexyl Phthalate | 2 | 2023 | 9 | 0.760 |
Why?
|
Bacterial Infections | 2 | 2021 | 222 | 0.750 |
Why?
|
Rats, Sprague-Dawley | 14 | 2021 | 2262 | 0.750 |
Why?
|
Lysophospholipids | 5 | 2023 | 65 | 0.750 |
Why?
|
Blood Chemical Analysis | 3 | 2010 | 90 | 0.750 |
Why?
|
Fatty Acid Desaturases | 1 | 2021 | 30 | 0.740 |
Why?
|
Running | 2 | 2022 | 209 | 0.740 |
Why?
|
Phosphates | 4 | 2023 | 160 | 0.730 |
Why?
|
Zika Virus Infection | 1 | 2022 | 85 | 0.730 |
Why?
|
Nitrogen | 3 | 2020 | 148 | 0.730 |
Why?
|
Pancreatic Cyst | 1 | 2021 | 47 | 0.730 |
Why?
|
Non-alcoholic Fatty Liver Disease | 5 | 2023 | 246 | 0.730 |
Why?
|
Cell Death | 2 | 2020 | 326 | 0.730 |
Why?
|
Glucuronates | 1 | 2020 | 4 | 0.720 |
Why?
|
Milk Proteins | 2 | 2010 | 36 | 0.720 |
Why?
|
Coffee | 1 | 2020 | 11 | 0.720 |
Why?
|
Adenosine | 14 | 2023 | 203 | 0.710 |
Why?
|
Antineoplastic Agents | 11 | 2021 | 1893 | 0.710 |
Why?
|
Torpor | 2 | 2020 | 14 | 0.700 |
Why?
|
Taurine | 1 | 2020 | 41 | 0.690 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 6 | 2020 | 171 | 0.690 |
Why?
|
Caffeine | 1 | 2020 | 58 | 0.690 |
Why?
|
Nuclear Proteins | 5 | 2021 | 594 | 0.680 |
Why?
|
Brain Death | 3 | 2016 | 32 | 0.680 |
Why?
|
Physical Exertion | 1 | 2021 | 206 | 0.680 |
Why?
|
Thrombosis | 5 | 2023 | 302 | 0.680 |
Why?
|
Adenocarcinoma | 3 | 2019 | 799 | 0.680 |
Why?
|
Iron | 3 | 2018 | 235 | 0.680 |
Why?
|
Parabiosis | 1 | 2019 | 12 | 0.680 |
Why?
|
Erythrocyte Deformability | 4 | 2023 | 12 | 0.670 |
Why?
|
Oxidative Phosphorylation | 11 | 2022 | 156 | 0.670 |
Why?
|
Endothelial Cells | 9 | 2023 | 695 | 0.670 |
Why?
|
Asparagine | 2 | 2018 | 29 | 0.670 |
Why?
|
Gene Expression Regulation | 16 | 2021 | 2353 | 0.670 |
Why?
|
2,3-Diphosphoglycerate | 8 | 2023 | 27 | 0.670 |
Why?
|
Prenatal Exposure Delayed Effects | 7 | 2021 | 447 | 0.670 |
Why?
|
Erythrocyte Aging | 3 | 2017 | 6 | 0.670 |
Why?
|
Refrigeration | 2 | 2017 | 11 | 0.670 |
Why?
|
Arousal | 2 | 2020 | 153 | 0.660 |
Why?
|
Temperature | 4 | 2021 | 587 | 0.660 |
Why?
|
Proteostasis | 2 | 2020 | 20 | 0.660 |
Why?
|
Citric Acid | 2 | 2016 | 30 | 0.660 |
Why?
|
Lipid Metabolism | 11 | 2023 | 449 | 0.660 |
Why?
|
Rats | 19 | 2023 | 5034 | 0.650 |
Why?
|
Arginine | 5 | 2022 | 241 | 0.650 |
Why?
|
Citrates | 2 | 2017 | 44 | 0.640 |
Why?
|
Drosophila melanogaster | 6 | 2024 | 190 | 0.640 |
Why?
|
Middle Aged | 52 | 2023 | 26999 | 0.630 |
Why?
|
Aspartic Acid | 1 | 2018 | 79 | 0.630 |
Why?
|
Blood Specimen Collection | 1 | 2018 | 32 | 0.630 |
Why?
|
Blood Component Transfusion | 3 | 2015 | 76 | 0.630 |
Why?
|
Gluconates | 1 | 2018 | 4 | 0.630 |
Why?
|
Complement System Proteins | 2 | 2021 | 288 | 0.630 |
Why?
|
Antacids | 1 | 2018 | 15 | 0.620 |
Why?
|
Fetal Blood | 2 | 2010 | 268 | 0.620 |
Why?
|
Extracellular Vesicles | 4 | 2023 | 83 | 0.610 |
Why?
|
Guanosine | 1 | 2018 | 39 | 0.610 |
Why?
|
Blood Coagulation | 6 | 2023 | 221 | 0.610 |
Why?
|
Mesentery | 2 | 2014 | 53 | 0.600 |
Why?
|
Hemoglobin, Sickle | 3 | 2023 | 14 | 0.600 |
Why?
|
Hypoxanthine | 1 | 2017 | 10 | 0.600 |
Why?
|
Ischemic Preconditioning | 1 | 2018 | 28 | 0.600 |
Why?
|
Brain Injuries, Traumatic | 4 | 2023 | 301 | 0.600 |
Why?
|
Apoptosis | 15 | 2022 | 2377 | 0.600 |
Why?
|
Swine | 6 | 2023 | 704 | 0.590 |
Why?
|
Prognosis | 6 | 2021 | 3339 | 0.590 |
Why?
|
Models, Biological | 8 | 2021 | 1646 | 0.580 |
Why?
|
Betacoronavirus | 4 | 2020 | 254 | 0.580 |
Why?
|
Resuscitation | 4 | 2022 | 247 | 0.570 |
Why?
|
Metabolic Networks and Pathways | 8 | 2023 | 168 | 0.570 |
Why?
|
Leukemia | 4 | 2020 | 209 | 0.570 |
Why?
|
Cadmium | 2 | 2015 | 58 | 0.570 |
Why?
|
RNA-Binding Proteins | 6 | 2023 | 362 | 0.560 |
Why?
|
Biomarkers, Tumor | 2 | 2021 | 1048 | 0.560 |
Why?
|
Hemorrhage | 5 | 2023 | 618 | 0.560 |
Why?
|
Kidney Transplantation | 15 | 2016 | 558 | 0.560 |
Why?
|
Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.550 |
Why?
|
Mannitol | 3 | 2022 | 32 | 0.550 |
Why?
|
Cellular Senescence | 2 | 2020 | 153 | 0.540 |
Why?
|
Exercise | 3 | 2023 | 1609 | 0.540 |
Why?
|
Hemoglobins | 8 | 2022 | 312 | 0.540 |
Why?
|
Body Fluids | 2 | 2017 | 58 | 0.530 |
Why?
|
Antioxidants | 5 | 2023 | 533 | 0.530 |
Why?
|
Systems Biology | 2 | 2013 | 57 | 0.520 |
Why?
|
Glutamine | 6 | 2023 | 91 | 0.520 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 340 | 0.520 |
Why?
|
Metabolic Flux Analysis | 1 | 2015 | 7 | 0.520 |
Why?
|
Fluid Therapy | 1 | 2016 | 122 | 0.510 |
Why?
|
Acidosis | 1 | 2016 | 87 | 0.510 |
Why?
|
Acetaminophen | 3 | 2023 | 237 | 0.510 |
Why?
|
Mutation | 13 | 2024 | 3364 | 0.500 |
Why?
|
Tissue Donors | 8 | 2016 | 331 | 0.500 |
Why?
|
Sphingosine | 3 | 2023 | 32 | 0.500 |
Why?
|
Fatty Acids, Nonesterified | 3 | 2022 | 151 | 0.500 |
Why?
|
Fibrinolysis | 4 | 2019 | 160 | 0.500 |
Why?
|
Cold Temperature | 6 | 2021 | 128 | 0.500 |
Why?
|
Ischemia | 2 | 2019 | 363 | 0.500 |
Why?
|
Blood Volume | 1 | 2015 | 56 | 0.490 |
Why?
|
Breast Neoplasms | 6 | 2023 | 1872 | 0.490 |
Why?
|
Sulfonamides | 6 | 2020 | 447 | 0.490 |
Why?
|
Sulfur | 3 | 2022 | 45 | 0.490 |
Why?
|
Exercise Tolerance | 3 | 2023 | 223 | 0.480 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2021 | 145 | 0.480 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2022 | 449 | 0.480 |
Why?
|
Alcohol Drinking | 1 | 2020 | 648 | 0.470 |
Why?
|
Lactates | 4 | 2023 | 83 | 0.470 |
Why?
|
Liver Transplantation | 14 | 2019 | 830 | 0.470 |
Why?
|
Chromatography, Reverse-Phase | 2 | 2012 | 26 | 0.470 |
Why?
|
Receptor, Adenosine A2B | 3 | 2021 | 30 | 0.470 |
Why?
|
Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2014 | 7 | 0.470 |
Why?
|
Precision Medicine | 4 | 2019 | 344 | 0.470 |
Why?
|
Octreotide | 1 | 2014 | 25 | 0.460 |
Why?
|
Plant Transpiration | 1 | 2013 | 5 | 0.460 |
Why?
|
Mustard Plant | 1 | 2013 | 2 | 0.460 |
Why?
|
Methionine | 3 | 2020 | 145 | 0.460 |
Why?
|
Substance P | 1 | 2014 | 44 | 0.460 |
Why?
|
Biomedical Research | 3 | 2021 | 588 | 0.450 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2014 | 139 | 0.450 |
Why?
|
Neurotransmitter Agents | 1 | 2014 | 77 | 0.450 |
Why?
|
AMP-Activated Protein Kinases | 6 | 2023 | 175 | 0.450 |
Why?
|
Homeostasis | 8 | 2023 | 577 | 0.450 |
Why?
|
Bile Acids and Salts | 4 | 2023 | 172 | 0.450 |
Why?
|
Mice, Knockout | 12 | 2023 | 2604 | 0.450 |
Why?
|
Cholestasis | 3 | 2021 | 225 | 0.440 |
Why?
|
Interleukin-1beta | 6 | 2021 | 370 | 0.440 |
Why?
|
Glutathione Disulfide | 2 | 2021 | 27 | 0.440 |
Why?
|
Fetal Development | 6 | 2021 | 247 | 0.440 |
Why?
|
Quality Control | 3 | 2022 | 147 | 0.430 |
Why?
|
Transcriptome | 4 | 2022 | 736 | 0.430 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2023 | 693 | 0.430 |
Why?
|
Photosynthesis | 1 | 2013 | 76 | 0.430 |
Why?
|
Acclimatization | 4 | 2018 | 132 | 0.430 |
Why?
|
Hemostatics | 2 | 2023 | 48 | 0.430 |
Why?
|
Homeodomain Proteins | 4 | 2020 | 465 | 0.420 |
Why?
|
Serpins | 3 | 2022 | 27 | 0.420 |
Why?
|
Endothelium, Vascular | 5 | 2021 | 845 | 0.410 |
Why?
|
Plateletpheresis | 3 | 2019 | 25 | 0.410 |
Why?
|
Chronic Disease | 2 | 2017 | 1598 | 0.410 |
Why?
|
Lipids | 6 | 2023 | 588 | 0.410 |
Why?
|
Critical Illness | 1 | 2017 | 645 | 0.410 |
Why?
|
MicroRNAs | 6 | 2018 | 607 | 0.410 |
Why?
|
Cells, Cultured | 17 | 2021 | 3914 | 0.410 |
Why?
|
Chromatography, Liquid | 4 | 2019 | 347 | 0.410 |
Why?
|
Calcium | 6 | 2023 | 1103 | 0.410 |
Why?
|
Parenteral Nutrition | 3 | 2021 | 93 | 0.400 |
Why?
|
Fibroblasts | 5 | 2021 | 839 | 0.400 |
Why?
|
Environmental Pollutants | 1 | 2013 | 111 | 0.400 |
Why?
|
Plasticizers | 3 | 2023 | 12 | 0.390 |
Why?
|
Blastocyst | 1 | 2011 | 43 | 0.390 |
Why?
|
Food Safety | 1 | 2011 | 15 | 0.390 |
Why?
|
Retina | 1 | 2014 | 267 | 0.390 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2020 | 289 | 0.390 |
Why?
|
Dietary Proteins | 1 | 2012 | 123 | 0.390 |
Why?
|
Stress, Physiological | 2 | 2018 | 399 | 0.390 |
Why?
|
Cell Proliferation | 14 | 2023 | 2194 | 0.380 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2021 | 195 | 0.380 |
Why?
|
Erythrocyte Count | 2 | 2021 | 19 | 0.380 |
Why?
|
Transplantation, Autologous | 3 | 2023 | 173 | 0.380 |
Why?
|
Death, Sudden, Cardiac | 2 | 2009 | 160 | 0.380 |
Why?
|
Docosahexaenoic Acids | 1 | 2011 | 69 | 0.370 |
Why?
|
Reactive Nitrogen Species | 1 | 2011 | 24 | 0.370 |
Why?
|
Lung Diseases | 1 | 2017 | 710 | 0.370 |
Why?
|
Anemia | 2 | 2023 | 144 | 0.370 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 185 | 0.370 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 2098 | 0.370 |
Why?
|
Chemical and Drug Induced Liver Injury | 2 | 2023 | 126 | 0.370 |
Why?
|
Pregnancy | 17 | 2022 | 5548 | 0.370 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2022 | 249 | 0.370 |
Why?
|
Kidney Failure, Chronic | 4 | 2016 | 490 | 0.370 |
Why?
|
Interleukin-1 | 3 | 2021 | 971 | 0.370 |
Why?
|
Blood Glucose | 4 | 2020 | 1824 | 0.360 |
Why?
|
Brain | 8 | 2021 | 2370 | 0.360 |
Why?
|
Medicine | 1 | 2012 | 103 | 0.360 |
Why?
|
DNA-Binding Proteins | 2 | 2016 | 1316 | 0.360 |
Why?
|
Oxygen Consumption | 5 | 2021 | 573 | 0.360 |
Why?
|
Young Adult | 17 | 2022 | 10470 | 0.360 |
Why?
|
Hydrogen-Ion Concentration | 6 | 2023 | 515 | 0.360 |
Why?
|
NF-kappa B | 5 | 2021 | 639 | 0.360 |
Why?
|
Gastrointestinal Microbiome | 4 | 2020 | 503 | 0.350 |
Why?
|
Heat-Shock Proteins | 1 | 2010 | 113 | 0.350 |
Why?
|
Egg Proteins | 1 | 2010 | 19 | 0.350 |
Why?
|
Food | 1 | 2011 | 160 | 0.350 |
Why?
|
Dendritic Cells | 4 | 2021 | 438 | 0.350 |
Why?
|
STAT3 Transcription Factor | 2 | 2022 | 174 | 0.350 |
Why?
|
Proteolysis | 4 | 2020 | 145 | 0.350 |
Why?
|
Urinary Diversion | 1 | 2009 | 11 | 0.350 |
Why?
|
Pyruvates | 4 | 2023 | 20 | 0.340 |
Why?
|
Flavones | 2 | 2019 | 10 | 0.340 |
Why?
|
Nitric Oxide | 4 | 2022 | 832 | 0.340 |
Why?
|
Tissue and Organ Procurement | 5 | 2016 | 243 | 0.340 |
Why?
|
Pharmacogenetics | 1 | 2010 | 151 | 0.340 |
Why?
|
Transcription Factors | 3 | 2023 | 1528 | 0.330 |
Why?
|
Myelodysplastic Syndromes | 2 | 2023 | 119 | 0.330 |
Why?
|
Neutrophils | 6 | 2022 | 1172 | 0.330 |
Why?
|
Tissue Plasminogen Activator | 4 | 2023 | 228 | 0.330 |
Why?
|
Superoxide Dismutase | 1 | 2011 | 332 | 0.330 |
Why?
|
Tryptophan Oxygenase | 3 | 2018 | 22 | 0.330 |
Why?
|
Milk, Human | 1 | 2010 | 128 | 0.330 |
Why?
|
Fetus | 4 | 2020 | 702 | 0.320 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 2 | 2020 | 12 | 0.320 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2021 | 183 | 0.320 |
Why?
|
Sex Characteristics | 6 | 2023 | 641 | 0.320 |
Why?
|
Nitriles | 2 | 2020 | 152 | 0.320 |
Why?
|
Head and Neck Neoplasms | 2 | 2023 | 425 | 0.320 |
Why?
|
Genome-Wide Association Study | 3 | 2023 | 1217 | 0.320 |
Why?
|
Platelet Function Tests | 2 | 2020 | 24 | 0.310 |
Why?
|
Alanine Transaminase | 4 | 2023 | 141 | 0.310 |
Why?
|
Isoantibodies | 2 | 2023 | 52 | 0.310 |
Why?
|
Obesity | 6 | 2021 | 2517 | 0.310 |
Why?
|
Models, Molecular | 4 | 2021 | 1390 | 0.310 |
Why?
|
Gestational Age | 5 | 2022 | 757 | 0.310 |
Why?
|
Inflammasomes | 2 | 2020 | 116 | 0.300 |
Why?
|
Nanoparticles | 2 | 2022 | 316 | 0.300 |
Why?
|
Neoplasm Proteins | 3 | 2021 | 385 | 0.300 |
Why?
|
Polypyrimidine Tract-Binding Protein | 2 | 2017 | 14 | 0.300 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2017 | 19 | 0.300 |
Why?
|
Maternal Exposure | 2 | 2019 | 138 | 0.300 |
Why?
|
Nitrogen Isotopes | 2 | 2017 | 55 | 0.300 |
Why?
|
Tumor Microenvironment | 5 | 2022 | 431 | 0.300 |
Why?
|
Hypertension | 4 | 2021 | 1064 | 0.300 |
Why?
|
Cell Survival | 7 | 2022 | 1024 | 0.290 |
Why?
|
Lymphatic Vessels | 2 | 2020 | 54 | 0.290 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 2 | 2018 | 63 | 0.290 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 177 | 0.290 |
Why?
|
Lung | 8 | 2023 | 3672 | 0.290 |
Why?
|
Carbon Isotopes | 2 | 2017 | 110 | 0.290 |
Why?
|
Phenotype | 10 | 2023 | 2829 | 0.290 |
Why?
|
Genomics | 1 | 2012 | 645 | 0.290 |
Why?
|
Cell Line | 10 | 2023 | 2651 | 0.290 |
Why?
|
Macrophages, Alveolar | 2 | 2021 | 357 | 0.290 |
Why?
|
Multiple Sclerosis | 2 | 2023 | 380 | 0.290 |
Why?
|
Graft Rejection | 10 | 2016 | 533 | 0.290 |
Why?
|
Thrombelastography | 3 | 2023 | 179 | 0.290 |
Why?
|
Cysteine | 2 | 2019 | 173 | 0.280 |
Why?
|
Saline Solution, Hypertonic | 2 | 2017 | 53 | 0.280 |
Why?
|
Membrane Proteins | 3 | 2023 | 1024 | 0.280 |
Why?
|
Interferons | 3 | 2023 | 152 | 0.280 |
Why?
|
Cell Cycle Proteins | 4 | 2022 | 553 | 0.280 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2017 | 43 | 0.280 |
Why?
|
Spermidine | 2 | 2024 | 18 | 0.280 |
Why?
|
Hyperaldosteronism | 2 | 2019 | 8 | 0.280 |
Why?
|
Cognitive Dysfunction | 2 | 2021 | 279 | 0.280 |
Why?
|
Microglia | 3 | 2023 | 203 | 0.280 |
Why?
|
Cholesterol | 4 | 2023 | 369 | 0.280 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2016 | 49 | 0.270 |
Why?
|
Epithelial-Mesenchymal Transition | 4 | 2021 | 167 | 0.270 |
Why?
|
Tandem Mass Spectrometry | 4 | 2016 | 414 | 0.270 |
Why?
|
Longitudinal Studies | 2 | 2023 | 2416 | 0.270 |
Why?
|
Familial Primary Pulmonary Hypertension | 2 | 2017 | 191 | 0.270 |
Why?
|
Reproducibility of Results | 5 | 2018 | 2800 | 0.270 |
Why?
|
Cytokines | 8 | 2023 | 1853 | 0.270 |
Why?
|
Insulin Resistance | 3 | 2021 | 1078 | 0.270 |
Why?
|
Blood Safety | 3 | 2017 | 10 | 0.270 |
Why?
|
Anti-Inflammatory Agents | 2 | 2021 | 448 | 0.270 |
Why?
|
Anaerobiosis | 4 | 2017 | 49 | 0.270 |
Why?
|
Solutions | 4 | 2018 | 150 | 0.260 |
Why?
|
Lipoproteins | 3 | 2021 | 162 | 0.260 |
Why?
|
Drosophila | 2 | 2024 | 132 | 0.260 |
Why?
|
Isotonic Solutions | 2 | 2016 | 38 | 0.260 |
Why?
|
Urea | 3 | 2023 | 69 | 0.260 |
Why?
|
Aged | 20 | 2023 | 19251 | 0.260 |
Why?
|
Down Syndrome | 2 | 2021 | 336 | 0.260 |
Why?
|
Cell Hypoxia | 3 | 2022 | 220 | 0.260 |
Why?
|
Case-Control Studies | 7 | 2022 | 3022 | 0.260 |
Why?
|
Organ Preservation | 8 | 1999 | 68 | 0.250 |
Why?
|
Graft Survival | 15 | 2016 | 480 | 0.250 |
Why?
|
Cell Self Renewal | 3 | 2021 | 49 | 0.250 |
Why?
|
Mice, Inbred NOD | 7 | 2021 | 560 | 0.250 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 1536 | 0.250 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2022 | 795 | 0.250 |
Why?
|
Interleukin-2 | 2 | 2023 | 417 | 0.250 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 7 | 2015 | 101 | 0.250 |
Why?
|
In Vitro Techniques | 4 | 2021 | 1044 | 0.250 |
Why?
|
RNA | 2 | 2023 | 819 | 0.250 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 107 | 0.250 |
Why?
|
Biological Transport | 3 | 2018 | 375 | 0.250 |
Why?
|
Lysine | 4 | 2019 | 245 | 0.240 |
Why?
|
Random Allocation | 2 | 2023 | 337 | 0.240 |
Why?
|
Triple Negative Breast Neoplasms | 2 | 2018 | 157 | 0.240 |
Why?
|
Gene Expression | 5 | 2022 | 1435 | 0.240 |
Why?
|
Mitochondria, Muscle | 4 | 2021 | 92 | 0.240 |
Why?
|
Reference Standards | 2 | 2017 | 161 | 0.240 |
Why?
|
Multiple Myeloma | 2 | 2023 | 93 | 0.240 |
Why?
|
Phosphoproteins | 3 | 2023 | 304 | 0.240 |
Why?
|
Computational Biology | 3 | 2014 | 536 | 0.240 |
Why?
|
Inflammation Mediators | 4 | 2021 | 479 | 0.240 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2023 | 85 | 0.240 |
Why?
|
Listeriosis | 2 | 2021 | 61 | 0.240 |
Why?
|
Mice, Transgenic | 8 | 2022 | 1970 | 0.240 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2023 | 794 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 1147 | 0.230 |
Why?
|
Pyruvic Acid | 3 | 2021 | 41 | 0.230 |
Why?
|
Thrombocythemia, Essential | 1 | 2024 | 6 | 0.230 |
Why?
|
ATP-Binding Cassette Transporters | 2 | 2023 | 123 | 0.230 |
Why?
|
Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.230 |
Why?
|
Machine Learning | 3 | 2023 | 321 | 0.230 |
Why?
|
Immunomodulation | 2 | 2022 | 85 | 0.230 |
Why?
|
Gas Chromatography-Mass Spectrometry | 3 | 2021 | 125 | 0.230 |
Why?
|
Hydroxyurea | 1 | 2023 | 30 | 0.230 |
Why?
|
Cell Respiration | 6 | 2021 | 74 | 0.230 |
Why?
|
Myeloproliferative Disorders | 1 | 2024 | 26 | 0.230 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2023 | 21 | 0.230 |
Why?
|
Reticulocytes | 1 | 2023 | 16 | 0.230 |
Why?
|
C-Reactive Protein | 3 | 2022 | 364 | 0.230 |
Why?
|
Amino Acid Sequence | 4 | 2019 | 2000 | 0.230 |
Why?
|
Hexokinase | 1 | 2023 | 10 | 0.230 |
Why?
|
Listeria monocytogenes | 2 | 2021 | 111 | 0.230 |
Why?
|
Microchip Analytical Procedures | 1 | 2023 | 5 | 0.230 |
Why?
|
AMP Deaminase | 1 | 2023 | 9 | 0.230 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2019 | 214 | 0.230 |
Why?
|
Phthalic Acids | 1 | 2023 | 28 | 0.230 |
Why?
|
NADP | 4 | 2021 | 42 | 0.220 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2022 | 274 | 0.220 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2023 | 25 | 0.220 |
Why?
|
Epithelial Cells | 3 | 2021 | 961 | 0.220 |
Why?
|
Limb Buds | 1 | 2023 | 20 | 0.220 |
Why?
|
Dietary Supplements | 4 | 2022 | 458 | 0.220 |
Why?
|
Insulin | 10 | 2021 | 2082 | 0.220 |
Why?
|
Infant Behavior | 2 | 2020 | 23 | 0.220 |
Why?
|
Osmotic Pressure | 2 | 2020 | 28 | 0.220 |
Why?
|
Succinates | 1 | 2023 | 18 | 0.220 |
Why?
|
Africa South of the Sahara | 1 | 2023 | 37 | 0.220 |
Why?
|
Protein C | 1 | 2023 | 44 | 0.220 |
Why?
|
Macrophage Activation | 2 | 2021 | 165 | 0.220 |
Why?
|
Pteridines | 1 | 2023 | 21 | 0.220 |
Why?
|
Quantitative Trait Loci | 2 | 2022 | 313 | 0.220 |
Why?
|
Molecular Dynamics Simulation | 2 | 2022 | 209 | 0.220 |
Why?
|
Giant Cell Arteritis | 1 | 2023 | 48 | 0.220 |
Why?
|
Glutamic Acid | 3 | 2017 | 213 | 0.220 |
Why?
|
Hematopoiesis | 3 | 2021 | 173 | 0.220 |
Why?
|
Fructose | 1 | 2023 | 100 | 0.220 |
Why?
|
Carbon Dioxide | 2 | 2015 | 211 | 0.220 |
Why?
|
Vinblastine | 1 | 2023 | 61 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2022 | 114 | 0.210 |
Why?
|
DNA Modification Methylases | 1 | 2022 | 14 | 0.210 |
Why?
|
Thrombophilia | 1 | 2023 | 66 | 0.210 |
Why?
|
Sirtuin 3 | 1 | 2023 | 52 | 0.210 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2023 | 95 | 0.210 |
Why?
|
Protein Kinase C-delta | 1 | 2023 | 70 | 0.210 |
Why?
|
Multiple Trauma | 1 | 2023 | 90 | 0.210 |
Why?
|
Radiation Tolerance | 1 | 2023 | 92 | 0.210 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 5 | 2017 | 312 | 0.210 |
Why?
|
Spectrin | 1 | 2022 | 13 | 0.210 |
Why?
|
Fibrinogen | 3 | 2023 | 160 | 0.210 |
Why?
|
src-Family Kinases | 1 | 2023 | 88 | 0.210 |
Why?
|
Imines | 1 | 2022 | 7 | 0.210 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 1361 | 0.210 |
Why?
|
Valosin Containing Protein | 1 | 2022 | 6 | 0.210 |
Why?
|
Erythroblasts | 1 | 2022 | 12 | 0.210 |
Why?
|
Neural Stem Cells | 1 | 2023 | 115 | 0.210 |
Why?
|
Bicycling | 1 | 2023 | 74 | 0.210 |
Why?
|
Electron Transport Complex II | 2 | 2019 | 23 | 0.210 |
Why?
|
Mice, SCID | 5 | 2021 | 321 | 0.210 |
Why?
|
Gene Regulatory Networks | 4 | 2014 | 231 | 0.210 |
Why?
|
Aldehydes | 1 | 2023 | 144 | 0.210 |
Why?
|
Complement C4 | 1 | 2022 | 26 | 0.210 |
Why?
|
Histiocytosis | 1 | 2022 | 8 | 0.210 |
Why?
|
Infant, Small for Gestational Age | 1 | 2022 | 75 | 0.200 |
Why?
|
Hydrogen Peroxide | 2 | 2021 | 287 | 0.200 |
Why?
|
Escherichia coli Proteins | 1 | 2023 | 164 | 0.200 |
Why?
|
Horses | 1 | 2022 | 97 | 0.200 |
Why?
|
Cohort Studies | 6 | 2023 | 4944 | 0.200 |
Why?
|
Balloon Occlusion | 1 | 2022 | 26 | 0.200 |
Why?
|
Coagulants | 2 | 2012 | 12 | 0.200 |
Why?
|
Amino Acid Transport System ASC | 1 | 2022 | 10 | 0.200 |
Why?
|
Pancreas Transplantation | 7 | 2000 | 64 | 0.200 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 2125 | 0.200 |
Why?
|
Benzoquinones | 1 | 2022 | 44 | 0.200 |
Why?
|
Cytophagocytosis | 1 | 2022 | 10 | 0.200 |
Why?
|
Blast Injuries | 1 | 2022 | 43 | 0.200 |
Why?
|
RNA, Viral | 2 | 2023 | 565 | 0.200 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2021 | 239 | 0.200 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2022 | 21 | 0.200 |
Why?
|
Erdheim-Chester Disease | 1 | 2021 | 5 | 0.200 |
Why?
|
Glutathione S-Transferase pi | 1 | 2021 | 8 | 0.200 |
Why?
|
Factor VIII | 2 | 2012 | 54 | 0.200 |
Why?
|
Adipose Tissue | 3 | 2017 | 555 | 0.200 |
Why?
|
Biological Products | 2 | 2022 | 172 | 0.200 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2022 | 41 | 0.200 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2021 | 6 | 0.200 |
Why?
|
Biogenic Amines | 1 | 2021 | 4 | 0.200 |
Why?
|
Antimalarials | 1 | 2021 | 24 | 0.200 |
Why?
|
Athletes | 2 | 2022 | 323 | 0.200 |
Why?
|
Blood | 1 | 2022 | 97 | 0.200 |
Why?
|
Kidney | 5 | 2022 | 1207 | 0.200 |
Why?
|
Nervous System Malformations | 1 | 2022 | 34 | 0.200 |
Why?
|
Persea | 1 | 2021 | 1 | 0.200 |
Why?
|
Aurora Kinase B | 1 | 2021 | 7 | 0.200 |
Why?
|
Malaria, Falciparum | 1 | 2021 | 25 | 0.190 |
Why?
|
Isoxazoles | 1 | 2021 | 56 | 0.190 |
Why?
|
Polyketides | 1 | 2021 | 3 | 0.190 |
Why?
|
Phytosterols | 1 | 2021 | 11 | 0.190 |
Why?
|
Recombinant Proteins | 2 | 2022 | 1243 | 0.190 |
Why?
|
Resistance Training | 1 | 2023 | 116 | 0.190 |
Why?
|
Breathing Exercises | 1 | 2021 | 19 | 0.190 |
Why?
|
Thyroid Hormones | 1 | 2021 | 53 | 0.190 |
Why?
|
Inhalation | 1 | 2021 | 24 | 0.190 |
Why?
|
Primates | 2 | 2023 | 111 | 0.190 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 47 | 0.190 |
Why?
|
Respiratory Muscles | 1 | 2021 | 32 | 0.190 |
Why?
|
Sphingolipids | 2 | 2021 | 59 | 0.190 |
Why?
|
Glutaredoxins | 1 | 2021 | 11 | 0.190 |
Why?
|
Lipid Bilayers | 1 | 2022 | 101 | 0.190 |
Why?
|
Dogs | 1 | 2022 | 341 | 0.190 |
Why?
|
Myelopoiesis | 1 | 2021 | 6 | 0.190 |
Why?
|
Cannabidiol | 1 | 2022 | 59 | 0.190 |
Why?
|
Methylation | 2 | 2018 | 206 | 0.190 |
Why?
|
Cyst Fluid | 1 | 2021 | 27 | 0.190 |
Why?
|
Aniline Compounds | 1 | 2021 | 71 | 0.190 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2021 | 420 | 0.190 |
Why?
|
Cell Tracking | 1 | 2021 | 13 | 0.190 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 228 | 0.190 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 124 | 0.190 |
Why?
|
Auditory Pathways | 1 | 2021 | 54 | 0.190 |
Why?
|
Virulence Factors | 1 | 2022 | 139 | 0.190 |
Why?
|
Erythrocyte Indices | 3 | 2018 | 27 | 0.190 |
Why?
|
Syndecan-1 | 1 | 2020 | 28 | 0.190 |
Why?
|
Molecular Sequence Data | 3 | 2015 | 2790 | 0.190 |
Why?
|
Sheep | 2 | 2020 | 764 | 0.190 |
Why?
|
Maneb | 1 | 2020 | 7 | 0.190 |
Why?
|
Bronchopulmonary Sequestration | 1 | 2020 | 9 | 0.190 |
Why?
|
Gelsolin | 2 | 2014 | 9 | 0.190 |
Why?
|
Amyloid beta-Peptides | 1 | 2023 | 191 | 0.190 |
Why?
|
Pyrazines | 1 | 2021 | 70 | 0.190 |
Why?
|
Seroconversion | 1 | 2021 | 46 | 0.190 |
Why?
|
Cell Plasticity | 1 | 2021 | 24 | 0.180 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2021 | 90 | 0.180 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2022 | 117 | 0.180 |
Why?
|
Sodium Nitrite | 1 | 2021 | 37 | 0.180 |
Why?
|
Azacitidine | 2 | 2018 | 130 | 0.180 |
Why?
|
Benzothiazoles | 2 | 2017 | 33 | 0.180 |
Why?
|
Cannabinoids | 1 | 2022 | 116 | 0.180 |
Why?
|
Cystine | 1 | 2020 | 14 | 0.180 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 93 | 0.180 |
Why?
|
Membrane Transport Proteins | 2 | 2023 | 137 | 0.180 |
Why?
|
Small Molecule Libraries | 1 | 2021 | 81 | 0.180 |
Why?
|
Immunoglobulin M | 1 | 2022 | 254 | 0.180 |
Why?
|
Cell Nucleus | 3 | 2018 | 553 | 0.180 |
Why?
|
Polymorphism, Genetic | 1 | 2023 | 621 | 0.180 |
Why?
|
Ammonia | 1 | 2020 | 57 | 0.180 |
Why?
|
Least-Squares Analysis | 2 | 2021 | 73 | 0.180 |
Why?
|
Antigens, Neoplasm | 2 | 2014 | 223 | 0.180 |
Why?
|
Epigenesis, Genetic | 3 | 2021 | 526 | 0.180 |
Why?
|
Staining and Labeling | 1 | 2021 | 139 | 0.180 |
Why?
|
Cadaver | 8 | 2009 | 316 | 0.180 |
Why?
|
Cellular Microenvironment | 1 | 2021 | 78 | 0.180 |
Why?
|
Electron Transport Chain Complex Proteins | 2 | 2019 | 18 | 0.180 |
Why?
|
Spike Glycoprotein, Coronavirus | 1 | 2021 | 94 | 0.180 |
Why?
|
Protein Unfolding | 1 | 2020 | 34 | 0.180 |
Why?
|
Preoperative Period | 2 | 2019 | 103 | 0.180 |
Why?
|
Antiviral Agents | 2 | 2023 | 651 | 0.180 |
Why?
|
Creatine | 1 | 2020 | 51 | 0.180 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 50 | 0.180 |
Why?
|
Lipase | 1 | 2020 | 66 | 0.180 |
Why?
|
Feces | 2 | 2019 | 372 | 0.180 |
Why?
|
Nonprescription Drugs | 1 | 2021 | 68 | 0.180 |
Why?
|
Myeloid-Derived Suppressor Cells | 1 | 2021 | 56 | 0.180 |
Why?
|
Databases, Genetic | 1 | 2021 | 208 | 0.180 |
Why?
|
Neutropenia | 1 | 2020 | 127 | 0.180 |
Why?
|
Thrombin | 4 | 2023 | 141 | 0.180 |
Why?
|
Lipoproteins, LDL | 1 | 2020 | 129 | 0.180 |
Why?
|
Phenylurea Compounds | 2 | 2017 | 83 | 0.180 |
Why?
|
Glioblastoma | 1 | 2022 | 253 | 0.180 |
Why?
|
Antigens, CD34 | 2 | 2010 | 90 | 0.170 |
Why?
|
Thyroid Neoplasms | 1 | 2023 | 262 | 0.170 |
Why?
|
TCF Transcription Factors | 1 | 2019 | 20 | 0.170 |
Why?
|
Escherichia coli | 1 | 2023 | 730 | 0.170 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2021 | 120 | 0.170 |
Why?
|
Iron Overload | 1 | 2019 | 10 | 0.170 |
Why?
|
Myeloid Cells | 1 | 2021 | 127 | 0.170 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2019 | 23 | 0.170 |
Why?
|
Shock | 1 | 2020 | 76 | 0.170 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 192 | 0.170 |
Why?
|
Lisinopril | 1 | 2019 | 14 | 0.170 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2019 | 31 | 0.170 |
Why?
|
Phosphatidylserines | 1 | 2020 | 87 | 0.170 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2019 | 15 | 0.170 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 118 | 0.170 |
Why?
|
Superoxides | 2 | 2017 | 215 | 0.170 |
Why?
|
Radiosurgery | 1 | 2022 | 298 | 0.170 |
Why?
|
Infant, Newborn | 8 | 2022 | 5077 | 0.170 |
Why?
|
RNA, Messenger | 4 | 2022 | 2574 | 0.170 |
Why?
|
Sirtuins | 1 | 2019 | 32 | 0.170 |
Why?
|
HEK293 Cells | 5 | 2021 | 602 | 0.170 |
Why?
|
Orthomyxoviridae Infections | 2 | 2018 | 55 | 0.170 |
Why?
|
Iron, Dietary | 1 | 2019 | 19 | 0.170 |
Why?
|
Receptors, Interferon | 1 | 2019 | 47 | 0.170 |
Why?
|
DNA Methylation | 2 | 2022 | 498 | 0.170 |
Why?
|
Histones | 2 | 2022 | 540 | 0.170 |
Why?
|
Hyperinsulinism | 1 | 2020 | 103 | 0.170 |
Why?
|
Chromium Radioisotopes | 1 | 2019 | 3 | 0.170 |
Why?
|
Liver Neoplasms | 3 | 2016 | 521 | 0.170 |
Why?
|
Sensory Gating | 1 | 2019 | 38 | 0.170 |
Why?
|
Hallucinogens | 1 | 2021 | 73 | 0.170 |
Why?
|
Factor XIIIa | 1 | 2019 | 5 | 0.170 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 258 | 0.170 |
Why?
|
Macaca mulatta | 1 | 2019 | 132 | 0.170 |
Why?
|
Child Development | 2 | 2021 | 389 | 0.170 |
Why?
|
Cell Membrane | 2 | 2022 | 683 | 0.170 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2020 | 704 | 0.170 |
Why?
|
Leukopoiesis | 1 | 2019 | 10 | 0.170 |
Why?
|
Myeloid Progenitor Cells | 1 | 2019 | 16 | 0.170 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2020 | 147 | 0.170 |
Why?
|
Essential Hypertension | 1 | 2019 | 3 | 0.170 |
Why?
|
NADPH Oxidase 2 | 1 | 2019 | 42 | 0.170 |
Why?
|
Prescription Drugs | 1 | 2021 | 116 | 0.160 |
Why?
|
Peptide Mapping | 1 | 2019 | 59 | 0.160 |
Why?
|
Mevalonic Acid | 1 | 2018 | 7 | 0.160 |
Why?
|
Trisomy | 1 | 2019 | 68 | 0.160 |
Why?
|
Cardio-Renal Syndrome | 1 | 2019 | 10 | 0.160 |
Why?
|
Prospective Studies | 6 | 2021 | 6264 | 0.160 |
Why?
|
Pharmaceutical Solutions | 1 | 2019 | 14 | 0.160 |
Why?
|
Motor Activity | 1 | 2024 | 633 | 0.160 |
Why?
|
Circadian Clocks | 1 | 2019 | 44 | 0.160 |
Why?
|
Diet, High-Fat | 4 | 2022 | 225 | 0.160 |
Why?
|
Heart Failure, Diastolic | 1 | 2019 | 20 | 0.160 |
Why?
|
Oxidoreductases | 1 | 2019 | 92 | 0.160 |
Why?
|
RNA Cleavage | 1 | 2018 | 7 | 0.160 |
Why?
|
Cigarette Smoking | 1 | 2020 | 80 | 0.160 |
Why?
|
Transcription Termination, Genetic | 1 | 2018 | 12 | 0.160 |
Why?
|
RNA Precursors | 1 | 2020 | 136 | 0.160 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2016 | 73 | 0.160 |
Why?
|
Hepatocytes | 4 | 2021 | 197 | 0.160 |
Why?
|
Fibrin | 1 | 2019 | 65 | 0.160 |
Why?
|
Transcription Elongation, Genetic | 1 | 2018 | 20 | 0.160 |
Why?
|
Acute Disease | 1 | 2021 | 914 | 0.160 |
Why?
|
Lipopolysaccharides | 5 | 2021 | 826 | 0.160 |
Why?
|
Creatinine | 1 | 2020 | 430 | 0.160 |
Why?
|
Click Chemistry | 1 | 2019 | 50 | 0.160 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2018 | 482 | 0.160 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 344 | 0.160 |
Why?
|
Enzyme Activation | 4 | 2023 | 793 | 0.160 |
Why?
|
Antibodies, Viral | 1 | 2022 | 527 | 0.160 |
Why?
|
Oxidants | 1 | 2019 | 112 | 0.160 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 113 | 0.160 |
Why?
|
Gene-Environment Interaction | 1 | 2020 | 184 | 0.160 |
Why?
|
Coenzymes | 1 | 2018 | 16 | 0.160 |
Why?
|
RNA Splicing | 1 | 2020 | 244 | 0.160 |
Why?
|
Eye Diseases, Hereditary | 1 | 2018 | 12 | 0.160 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 20 | 0.160 |
Why?
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2018 | 22 | 0.160 |
Why?
|
Mouse Embryonic Stem Cells | 1 | 2018 | 22 | 0.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 519 | 0.160 |
Why?
|
Vaccines, Subunit | 1 | 2018 | 41 | 0.160 |
Why?
|
Endovascular Procedures | 1 | 2022 | 269 | 0.150 |
Why?
|
Placental Insufficiency | 1 | 2019 | 102 | 0.150 |
Why?
|
Receptors, CCR2 | 1 | 2018 | 28 | 0.150 |
Why?
|
Diagnosis | 1 | 2018 | 9 | 0.150 |
Why?
|
Deamination | 1 | 2017 | 5 | 0.150 |
Why?
|
Therapeutics | 1 | 2018 | 12 | 0.150 |
Why?
|
Proof of Concept Study | 1 | 2018 | 44 | 0.150 |
Why?
|
Erythrocytes, Abnormal | 1 | 2017 | 13 | 0.150 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2018 | 77 | 0.150 |
Why?
|
Hemoglobin A | 1 | 2017 | 21 | 0.150 |
Why?
|
Premature Birth | 1 | 2021 | 278 | 0.150 |
Why?
|
Vascular Diseases | 1 | 2020 | 230 | 0.150 |
Why?
|
Blood Pressure | 2 | 2021 | 1537 | 0.150 |
Why?
|
Genetic Variation | 2 | 2020 | 877 | 0.150 |
Why?
|
Diglycerides | 1 | 2018 | 55 | 0.150 |
Why?
|
Hydroxylamine | 1 | 2017 | 8 | 0.150 |
Why?
|
Benzeneacetamides | 1 | 2017 | 7 | 0.150 |
Why?
|
Crush Injuries | 1 | 2017 | 10 | 0.150 |
Why?
|
Liquid-Liquid Extraction | 1 | 2017 | 15 | 0.150 |
Why?
|
Glutaminase | 1 | 2017 | 10 | 0.150 |
Why?
|
Infant | 8 | 2020 | 7979 | 0.150 |
Why?
|
Analysis of Variance | 2 | 2018 | 1227 | 0.150 |
Why?
|
Nicotine | 1 | 2020 | 266 | 0.150 |
Why?
|
Neurons | 4 | 2021 | 1298 | 0.150 |
Why?
|
Linear Models | 2 | 2017 | 776 | 0.150 |
Why?
|
Freezing | 1 | 2017 | 85 | 0.150 |
Why?
|
Cluster Analysis | 2 | 2016 | 465 | 0.150 |
Why?
|
Glycogen | 1 | 2017 | 52 | 0.150 |
Why?
|
Swine, Miniature | 1 | 2017 | 71 | 0.150 |
Why?
|
Thiadiazoles | 1 | 2017 | 21 | 0.150 |
Why?
|
Vitreous Body | 1 | 2018 | 102 | 0.150 |
Why?
|
Retinal Detachment | 1 | 2018 | 53 | 0.150 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 388 | 0.150 |
Why?
|
Multivariate Analysis | 2 | 2018 | 1440 | 0.150 |
Why?
|
Carrier Proteins | 1 | 2021 | 701 | 0.150 |
Why?
|
Metabolic Syndrome | 1 | 2021 | 324 | 0.150 |
Why?
|
Brain Injuries | 1 | 2022 | 451 | 0.140 |
Why?
|
Folic Acid Deficiency | 1 | 2017 | 48 | 0.140 |
Why?
|
Limit of Detection | 1 | 2017 | 55 | 0.140 |
Why?
|
Immune System | 1 | 2018 | 173 | 0.140 |
Why?
|
Bone Marrow | 1 | 2018 | 249 | 0.140 |
Why?
|
Culture Media | 2 | 2021 | 156 | 0.140 |
Why?
|
Anxiety | 1 | 2023 | 853 | 0.140 |
Why?
|
Body Mass Index | 2 | 2021 | 1971 | 0.140 |
Why?
|
Femoral Fractures | 1 | 2017 | 67 | 0.140 |
Why?
|
Specimen Handling | 2 | 2021 | 156 | 0.140 |
Why?
|
Cystathionine | 1 | 2016 | 25 | 0.140 |
Why?
|
Acute Lung Injury | 2 | 2017 | 300 | 0.140 |
Why?
|
Periodicity | 1 | 2016 | 56 | 0.140 |
Why?
|
United States Food and Drug Administration | 1 | 2017 | 173 | 0.140 |
Why?
|
Basigin | 1 | 2017 | 25 | 0.140 |
Why?
|
Immunologic Factors | 1 | 2019 | 220 | 0.140 |
Why?
|
Flow Cytometry | 3 | 2018 | 1083 | 0.140 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2018 | 141 | 0.140 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2024 | 332 | 0.140 |
Why?
|
Mammals | 3 | 2023 | 251 | 0.140 |
Why?
|
Transcriptional Activation | 1 | 2018 | 340 | 0.140 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 457 | 0.140 |
Why?
|
Health Status | 2 | 2019 | 728 | 0.140 |
Why?
|
Parkinson Disease | 1 | 2020 | 325 | 0.140 |
Why?
|
Riboflavin | 2 | 2014 | 7 | 0.140 |
Why?
|
T-Lymphocytes | 3 | 2019 | 1756 | 0.140 |
Why?
|
Isoenzymes | 1 | 2017 | 285 | 0.140 |
Why?
|
Protein Folding | 1 | 2018 | 243 | 0.140 |
Why?
|
Hydrogen Sulfide | 1 | 2016 | 40 | 0.140 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 92 | 0.140 |
Why?
|
Folic Acid | 1 | 2017 | 159 | 0.140 |
Why?
|
Alcohol Oxidoreductases | 1 | 2016 | 38 | 0.140 |
Why?
|
Color | 2 | 2019 | 75 | 0.140 |
Why?
|
Diabetic Retinopathy | 1 | 2018 | 149 | 0.140 |
Why?
|
Cell Differentiation | 2 | 2021 | 1700 | 0.140 |
Why?
|
DNA | 1 | 2023 | 1356 | 0.140 |
Why?
|
Discriminant Analysis | 1 | 2016 | 39 | 0.140 |
Why?
|
Reperfusion Injury | 1 | 2018 | 254 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2018 | 314 | 0.130 |
Why?
|
Succinate Dehydrogenase | 3 | 2022 | 41 | 0.130 |
Why?
|
Tumor Cells, Cultured | 3 | 2023 | 850 | 0.130 |
Why?
|
Recovery of Function | 1 | 2020 | 577 | 0.130 |
Why?
|
Bacteria | 1 | 2022 | 729 | 0.130 |
Why?
|
Orthomyxoviridae | 1 | 2016 | 35 | 0.130 |
Why?
|
Extracellular Matrix | 2 | 2017 | 439 | 0.130 |
Why?
|
Body Temperature | 1 | 2016 | 211 | 0.130 |
Why?
|
Severity of Illness Index | 2 | 2021 | 2578 | 0.130 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 432 | 0.130 |
Why?
|
Marijuana Smoking | 1 | 2019 | 224 | 0.130 |
Why?
|
Lower Extremity | 1 | 2019 | 337 | 0.130 |
Why?
|
RNA Polymerase II | 1 | 2018 | 283 | 0.130 |
Why?
|
Phosphatidylethanolamines | 1 | 2016 | 66 | 0.130 |
Why?
|
Organ Transplantation | 3 | 1998 | 161 | 0.130 |
Why?
|
Diet, Western | 3 | 2023 | 66 | 0.130 |
Why?
|
Monocytes | 3 | 2023 | 507 | 0.130 |
Why?
|
Sesquiterpenes | 2 | 2016 | 51 | 0.130 |
Why?
|
Vasodilation | 1 | 2018 | 412 | 0.130 |
Why?
|
Anoikis | 1 | 2015 | 31 | 0.130 |
Why?
|
Hydroxylysine | 1 | 2015 | 4 | 0.130 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2022 | 136 | 0.130 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2015 | 39 | 0.130 |
Why?
|
Immunity, Innate | 1 | 2021 | 731 | 0.130 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 1805 | 0.130 |
Why?
|
Phosphatidylcholines | 1 | 2016 | 134 | 0.130 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 3 | 2021 | 40 | 0.130 |
Why?
|
Brassicaceae | 1 | 2015 | 9 | 0.130 |
Why?
|
Trauma Centers | 1 | 2017 | 329 | 0.130 |
Why?
|
Drug Design | 2 | 2019 | 156 | 0.130 |
Why?
|
Taurocholic Acid | 1 | 2015 | 34 | 0.120 |
Why?
|
Nijmegen Breakage Syndrome | 1 | 2014 | 1 | 0.120 |
Why?
|
Glycocalyx | 1 | 2015 | 21 | 0.120 |
Why?
|
RNA Interference | 4 | 2017 | 438 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 4 | 2023 | 790 | 0.120 |
Why?
|
Extinction, Biological | 1 | 2015 | 29 | 0.120 |
Why?
|
Molecular Chaperones | 1 | 2016 | 157 | 0.120 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 4435 | 0.120 |
Why?
|
Serine Proteases | 1 | 2014 | 14 | 0.120 |
Why?
|
Europe | 1 | 2015 | 336 | 0.120 |
Why?
|
Kallikreins | 1 | 2014 | 30 | 0.120 |
Why?
|
Tissue Banks | 1 | 1994 | 18 | 0.120 |
Why?
|
Acute-Phase Proteins | 1 | 2014 | 64 | 0.120 |
Why?
|
Brain Neoplasms | 1 | 2022 | 980 | 0.120 |
Why?
|
Cytoskeletal Proteins | 1 | 2015 | 145 | 0.120 |
Why?
|
Vascular Remodeling | 3 | 2023 | 151 | 0.120 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 31 | 0.120 |
Why?
|
Thrombolytic Therapy | 1 | 2015 | 118 | 0.120 |
Why?
|
Peptide Fragments | 3 | 2013 | 675 | 0.120 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2017 | 608 | 0.120 |
Why?
|
Glycoproteins | 2 | 2013 | 309 | 0.120 |
Why?
|
Adolescent | 15 | 2022 | 17889 | 0.120 |
Why?
|
Pilot Projects | 4 | 2022 | 1377 | 0.120 |
Why?
|
Structure-Activity Relationship | 3 | 2021 | 511 | 0.120 |
Why?
|
Seasons | 1 | 2016 | 449 | 0.120 |
Why?
|
Cannabis | 1 | 2021 | 381 | 0.120 |
Why?
|
Phosphorylation | 5 | 2018 | 1571 | 0.120 |
Why?
|
Cations | 1 | 2014 | 79 | 0.120 |
Why?
|
Intestines | 1 | 2017 | 324 | 0.120 |
Why?
|
Sequence Deletion | 1 | 2014 | 167 | 0.120 |
Why?
|
Placenta | 1 | 2020 | 624 | 0.120 |
Why?
|
Mitochondrial Proteins | 1 | 2016 | 219 | 0.120 |
Why?
|
Neutrophil Activation | 1 | 2014 | 94 | 0.120 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 2 | 2012 | 165 | 0.120 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 1137 | 0.120 |
Why?
|
Free Radical Scavengers | 1 | 2014 | 82 | 0.120 |
Why?
|
Parasitic Diseases | 1 | 2014 | 7 | 0.120 |
Why?
|
Lipid Peroxidation | 1 | 2014 | 138 | 0.120 |
Why?
|
Immunoblotting | 1 | 2014 | 281 | 0.120 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2014 | 135 | 0.120 |
Why?
|
Peptide Hydrolases | 1 | 2014 | 109 | 0.110 |
Why?
|
Receptor, Notch1 | 1 | 2014 | 59 | 0.110 |
Why?
|
Infant, Premature | 1 | 2017 | 477 | 0.110 |
Why?
|
Tumor Protein p73 | 1 | 2013 | 15 | 0.110 |
Why?
|
Adrenal Glands | 1 | 2014 | 72 | 0.110 |
Why?
|
Mothers | 4 | 2021 | 666 | 0.110 |
Why?
|
Peptides | 1 | 2019 | 864 | 0.110 |
Why?
|
Ascorbic Acid | 1 | 2014 | 112 | 0.110 |
Why?
|
Ultraviolet Rays | 2 | 2014 | 372 | 0.110 |
Why?
|
Epidermal Growth Factor | 2 | 2004 | 161 | 0.110 |
Why?
|
Hyperplasia | 1 | 2014 | 166 | 0.110 |
Why?
|
Heart Ventricles | 1 | 2018 | 712 | 0.110 |
Why?
|
Phosphatidylinositols | 1 | 2013 | 53 | 0.110 |
Why?
|
Mental Disorders | 1 | 2021 | 902 | 0.110 |
Why?
|
Acetylcysteine | 1 | 2014 | 144 | 0.110 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2023 | 66 | 0.110 |
Why?
|
Proteins | 3 | 2023 | 920 | 0.110 |
Why?
|
Fibrinolytic Agents | 1 | 2015 | 233 | 0.110 |
Why?
|
Glucose Tolerance Test | 3 | 2021 | 344 | 0.110 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 617 | 0.110 |
Why?
|
Postmortem Changes | 1 | 2012 | 16 | 0.110 |
Why?
|
Up-Regulation | 3 | 2023 | 820 | 0.110 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2013 | 92 | 0.110 |
Why?
|
Anticoagulants | 2 | 2023 | 549 | 0.110 |
Why?
|
Collagen | 1 | 2015 | 415 | 0.110 |
Why?
|
Erythropoiesis | 2 | 2023 | 33 | 0.110 |
Why?
|
Diet | 1 | 2020 | 1072 | 0.110 |
Why?
|
Photosensitizing Agents | 1 | 2013 | 26 | 0.110 |
Why?
|
Heart Arrest | 1 | 2016 | 289 | 0.110 |
Why?
|
Gamma Rays | 1 | 2013 | 47 | 0.110 |
Why?
|
Larva | 3 | 2020 | 193 | 0.110 |
Why?
|
Carcinogenesis | 1 | 2014 | 178 | 0.110 |
Why?
|
Interferon-alpha | 2 | 2004 | 186 | 0.100 |
Why?
|
Cytoplasm | 1 | 2013 | 255 | 0.100 |
Why?
|
Doping in Sports | 1 | 2012 | 4 | 0.100 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 941 | 0.100 |
Why?
|
Taste Buds | 1 | 2015 | 209 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 1 | 2017 | 413 | 0.100 |
Why?
|
Lymph Nodes | 1 | 2015 | 423 | 0.100 |
Why?
|
Phosphoric Acids | 1 | 2012 | 16 | 0.100 |
Why?
|
Peroxiredoxins | 1 | 2012 | 23 | 0.100 |
Why?
|
Stem Cells | 3 | 2021 | 546 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 646 | 0.100 |
Why?
|
Transcription, Genetic | 2 | 2019 | 1310 | 0.100 |
Why?
|
Cell Extracts | 1 | 2012 | 16 | 0.100 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 145 | 0.100 |
Why?
|
Adenoma | 1 | 2014 | 187 | 0.100 |
Why?
|
Genetic Background | 2 | 2021 | 8 | 0.100 |
Why?
|
Multiple Organ Failure | 2 | 2022 | 144 | 0.100 |
Why?
|
Genetic Therapy | 1 | 2013 | 260 | 0.100 |
Why?
|
Colorado | 2 | 2021 | 4113 | 0.100 |
Why?
|
Embryo Culture Techniques | 1 | 2011 | 12 | 0.100 |
Why?
|
Embryo Implantation | 1 | 2011 | 23 | 0.100 |
Why?
|
Botrytis | 1 | 2011 | 1 | 0.100 |
Why?
|
Resorcinols | 1 | 2011 | 4 | 0.100 |
Why?
|
Wine | 1 | 2011 | 8 | 0.100 |
Why?
|
Plant Diseases | 1 | 2011 | 33 | 0.100 |
Why?
|
Sequence Analysis, RNA | 3 | 2021 | 390 | 0.100 |
Why?
|
Embryo Transfer | 1 | 2011 | 29 | 0.100 |
Why?
|
Virus Diseases | 1 | 2014 | 200 | 0.100 |
Why?
|
Crops, Agricultural | 1 | 2011 | 31 | 0.100 |
Why?
|
Sus scrofa | 1 | 2011 | 45 | 0.100 |
Why?
|
Trastuzumab | 2 | 2022 | 89 | 0.100 |
Why?
|
Calibration | 1 | 2012 | 127 | 0.100 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 535 | 0.100 |
Why?
|
Food Microbiology | 1 | 2011 | 57 | 0.100 |
Why?
|
Benzofurans | 1 | 2011 | 20 | 0.100 |
Why?
|
Protein Carbonylation | 1 | 2011 | 52 | 0.100 |
Why?
|
Microscopy, Electron, Scanning | 3 | 2018 | 194 | 0.100 |
Why?
|
Stilbenes | 1 | 2011 | 36 | 0.100 |
Why?
|
Datasets as Topic | 2 | 2022 | 99 | 0.100 |
Why?
|
Vitis | 1 | 2011 | 38 | 0.100 |
Why?
|
Bone Marrow Cells | 1 | 2012 | 268 | 0.100 |
Why?
|
Autophagy | 1 | 2013 | 236 | 0.100 |
Why?
|
Microbiota | 1 | 2018 | 652 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 399 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 503 | 0.090 |
Why?
|
Bile Duct Diseases | 1 | 2011 | 17 | 0.090 |
Why?
|
Survival Analysis | 5 | 2016 | 1219 | 0.090 |
Why?
|
ABO Blood-Group System | 1 | 2011 | 33 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 1870 | 0.090 |
Why?
|
Embryonic Development | 1 | 2011 | 115 | 0.090 |
Why?
|
Longevity | 2 | 2022 | 136 | 0.090 |
Why?
|
Phenols | 1 | 2011 | 82 | 0.090 |
Why?
|
Myofibrils | 2 | 2021 | 46 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 963 | 0.090 |
Why?
|
Aquaporin 4 | 1 | 2011 | 86 | 0.090 |
Why?
|
Fertility | 1 | 2011 | 131 | 0.090 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2021 | 44 | 0.090 |
Why?
|
Databases, Protein | 1 | 2010 | 59 | 0.090 |
Why?
|
Living Donors | 3 | 2008 | 324 | 0.090 |
Why?
|
Forecasting | 1 | 2012 | 333 | 0.090 |
Why?
|
Retrospective Studies | 11 | 2022 | 12608 | 0.090 |
Why?
|
Multidrug Resistance-Associated Proteins | 2 | 2021 | 36 | 0.090 |
Why?
|
Neuronal Plasticity | 2 | 2023 | 214 | 0.090 |
Why?
|
Erythroblastosis, Fetal | 1 | 2010 | 4 | 0.090 |
Why?
|
RNA, Small Interfering | 3 | 2017 | 544 | 0.090 |
Why?
|
Injury Severity Score | 3 | 2018 | 458 | 0.090 |
Why?
|
Nucleotides | 2 | 2023 | 113 | 0.090 |
Why?
|
Cell Shape | 1 | 2010 | 54 | 0.090 |
Why?
|
Pulmonary Artery | 3 | 2023 | 1031 | 0.090 |
Why?
|
Cell Size | 1 | 2010 | 81 | 0.090 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2022 | 3254 | 0.090 |
Why?
|
Ultrasonography | 2 | 2011 | 641 | 0.090 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2011 | 174 | 0.090 |
Why?
|
Breeding | 1 | 2009 | 55 | 0.090 |
Why?
|
Protein Binding | 3 | 2020 | 1917 | 0.080 |
Why?
|
Extracellular Matrix Proteins | 3 | 2017 | 127 | 0.080 |
Why?
|
Chickens | 1 | 2010 | 183 | 0.080 |
Why?
|
Bisphosphoglycerate Mutase | 2 | 2021 | 6 | 0.080 |
Why?
|
Tissue and Organ Harvesting | 1 | 2009 | 69 | 0.080 |
Why?
|
Fibrosis | 2 | 2023 | 457 | 0.080 |
Why?
|
United States | 4 | 2023 | 12295 | 0.080 |
Why?
|
Treatment Outcome | 9 | 2021 | 9159 | 0.080 |
Why?
|
Protein Isoforms | 2 | 2022 | 339 | 0.080 |
Why?
|
Glucose Clamp Technique | 2 | 2021 | 181 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2023 | 199 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 1724 | 0.080 |
Why?
|
Complement Activation | 2 | 2022 | 343 | 0.080 |
Why?
|
Maternal-Fetal Exchange | 1 | 2010 | 151 | 0.080 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2009 | 57 | 0.080 |
Why?
|
Child | 12 | 2023 | 18488 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2021 | 1918 | 0.080 |
Why?
|
Metabolism | 2 | 2019 | 36 | 0.080 |
Why?
|
Asthma | 1 | 2021 | 2066 | 0.080 |
Why?
|
Raffinose | 7 | 1999 | 20 | 0.080 |
Why?
|
Cell Movement | 3 | 2017 | 867 | 0.080 |
Why?
|
Allopurinol | 7 | 1999 | 55 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2023 | 1660 | 0.080 |
Why?
|
Antagomirs | 2 | 2017 | 13 | 0.080 |
Why?
|
Administration, Oral | 2 | 2020 | 734 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 315 | 0.080 |
Why?
|
Models, Animal | 2 | 2021 | 350 | 0.070 |
Why?
|
Monocarboxylic Acid Transporters | 2 | 2017 | 21 | 0.070 |
Why?
|
Heterozygote | 2 | 2021 | 252 | 0.070 |
Why?
|
Cell Lineage | 2 | 2021 | 310 | 0.070 |
Why?
|
Ubiquitination | 2 | 2018 | 86 | 0.070 |
Why?
|
Caspase 1 | 2 | 2018 | 141 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 1718 | 0.070 |
Why?
|
Sex Factors | 2 | 2023 | 1736 | 0.070 |
Why?
|
Protein Conformation | 2 | 2021 | 822 | 0.070 |
Why?
|
Kinetics | 2 | 2022 | 1569 | 0.070 |
Why?
|
GPI-Linked Proteins | 2 | 2017 | 54 | 0.070 |
Why?
|
5'-Nucleotidase | 2 | 2017 | 33 | 0.070 |
Why?
|
Spleen | 2 | 2019 | 492 | 0.070 |
Why?
|
Binding Sites | 2 | 2021 | 1177 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 348 | 0.070 |
Why?
|
Receptors, Interleukin-1 | 2 | 2018 | 227 | 0.070 |
Why?
|
Hemodynamics | 2 | 2021 | 968 | 0.070 |
Why?
|
Glomerular Filtration Rate | 2 | 2022 | 605 | 0.070 |
Why?
|
Cell Adhesion | 2 | 2018 | 433 | 0.070 |
Why?
|
Risk Factors | 5 | 2023 | 8697 | 0.070 |
Why?
|
Platelet Activation | 2 | 2019 | 68 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2019 | 2207 | 0.070 |
Why?
|
Mice, Nude | 2 | 2018 | 639 | 0.070 |
Why?
|
Osmotic Fragility | 2 | 2018 | 6 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 526 | 0.070 |
Why?
|
Interferon-gamma | 2 | 2021 | 726 | 0.060 |
Why?
|
Glycerol | 2 | 2018 | 86 | 0.060 |
Why?
|
Regression Analysis | 2 | 2019 | 959 | 0.060 |
Why?
|
Liver Diseases | 2 | 2021 | 263 | 0.060 |
Why?
|
Sarcolemma | 2 | 2018 | 29 | 0.060 |
Why?
|
Species Specificity | 3 | 2011 | 552 | 0.060 |
Why?
|
Hepatitis C | 1 | 2008 | 229 | 0.060 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2004 | 39 | 0.060 |
Why?
|
Indoleacetic Acids | 1 | 2024 | 4 | 0.060 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 31 | 0.060 |
Why?
|
Disease Progression | 2 | 2023 | 2418 | 0.060 |
Why?
|
Fish Oils | 1 | 2023 | 25 | 0.060 |
Why?
|
Respiratory Therapy | 1 | 2023 | 20 | 0.060 |
Why?
|
Dapsone | 1 | 2023 | 5 | 0.060 |
Why?
|
Maltose | 1 | 2023 | 5 | 0.060 |
Why?
|
A549 Cells | 1 | 2023 | 51 | 0.060 |
Why?
|
Metabolic Engineering | 1 | 2023 | 24 | 0.060 |
Why?
|
Peptide Initiation Factors | 1 | 2003 | 17 | 0.060 |
Why?
|
Monitoring, Immunologic | 1 | 2023 | 23 | 0.060 |
Why?
|
Pantothenic Acid | 1 | 2023 | 5 | 0.060 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2023 | 29 | 0.050 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2023 | 35 | 0.050 |
Why?
|
Factor XIII | 1 | 2023 | 7 | 0.050 |
Why?
|
Factor V | 1 | 2023 | 22 | 0.050 |
Why?
|
Thromboplastin | 1 | 2023 | 71 | 0.050 |
Why?
|
Dasatinib | 1 | 2023 | 46 | 0.050 |
Why?
|
Virus Internalization | 1 | 2023 | 41 | 0.050 |
Why?
|
1-Acylglycerophosphocholine O-Acyltransferase | 1 | 2022 | 5 | 0.050 |
Why?
|
Guanine | 1 | 2003 | 76 | 0.050 |
Why?
|
Sildenafil Citrate | 1 | 2023 | 58 | 0.050 |
Why?
|
Heme | 1 | 2023 | 56 | 0.050 |
Why?
|
Hand Strength | 1 | 2023 | 97 | 0.050 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 156 | 0.050 |
Why?
|
Blood Coagulation Tests | 1 | 2023 | 57 | 0.050 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2022 | 15 | 0.050 |
Why?
|
Postoperative Complications | 7 | 2000 | 2161 | 0.050 |
Why?
|
Iodine Radioisotopes | 1 | 2023 | 126 | 0.050 |
Why?
|
Inosine | 1 | 2022 | 11 | 0.050 |
Why?
|
Leukocytes | 2 | 2017 | 281 | 0.050 |
Why?
|
Arginase | 1 | 2022 | 27 | 0.050 |
Why?
|
Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 3 | 0.050 |
Why?
|
RNA Splicing Factors | 1 | 2023 | 50 | 0.050 |
Why?
|
Volunteers | 1 | 2022 | 31 | 0.050 |
Why?
|
Myocardium | 2 | 2019 | 926 | 0.050 |
Why?
|
PQQ Cofactor | 1 | 2022 | 5 | 0.050 |
Why?
|
Malates | 1 | 2022 | 5 | 0.050 |
Why?
|
Citrulline | 1 | 2022 | 39 | 0.050 |
Why?
|
Fumarates | 1 | 2022 | 10 | 0.050 |
Why?
|
PPAR alpha | 1 | 2022 | 52 | 0.050 |
Why?
|
Muscles | 1 | 2023 | 326 | 0.050 |
Why?
|
Quality of Life | 3 | 2023 | 2385 | 0.050 |
Why?
|
Carboxylic Acids | 1 | 2022 | 26 | 0.050 |
Why?
|
Solute Carrier Family 22 Member 5 | 1 | 2022 | 4 | 0.050 |
Why?
|
Thyroid Nodule | 1 | 2002 | 37 | 0.050 |
Why?
|
Histidine | 1 | 2022 | 57 | 0.050 |
Why?
|
Ovarian Follicle | 1 | 1982 | 61 | 0.050 |
Why?
|
Gram-Negative Bacteria | 1 | 2022 | 67 | 0.050 |
Why?
|
Solvents | 1 | 2002 | 108 | 0.050 |
Why?
|
Catalase | 1 | 2022 | 118 | 0.050 |
Why?
|
Adipocytes | 1 | 2023 | 188 | 0.050 |
Why?
|
Phenylalanine | 1 | 2022 | 58 | 0.050 |
Why?
|
Spermine | 1 | 2022 | 27 | 0.050 |
Why?
|
Ubiquitin | 1 | 2022 | 64 | 0.050 |
Why?
|
Animals, Wild | 1 | 2021 | 44 | 0.050 |
Why?
|
Disease Resistance | 1 | 2021 | 28 | 0.050 |
Why?
|
Intestinal Diseases | 1 | 2021 | 29 | 0.050 |
Why?
|
Caspases | 2 | 2018 | 245 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2024 | 400 | 0.050 |
Why?
|
Ketone Oxidoreductases | 1 | 2021 | 7 | 0.050 |
Why?
|
X-Ray Diffraction | 1 | 2021 | 84 | 0.050 |
Why?
|
Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2021 | 3 | 0.050 |
Why?
|
Hep G2 Cells | 1 | 2021 | 61 | 0.050 |
Why?
|
Plasmodium falciparum | 1 | 2021 | 27 | 0.050 |
Why?
|
Central Nervous System | 1 | 2023 | 239 | 0.050 |
Why?
|
Phospholipids | 1 | 2023 | 202 | 0.050 |
Why?
|
Embryo, Mammalian | 1 | 2022 | 214 | 0.050 |
Why?
|
Comorbidity | 3 | 2021 | 1473 | 0.050 |
Why?
|
Glutathione Transferase | 1 | 2021 | 95 | 0.050 |
Why?
|
Drug Resistance, Multiple | 1 | 2021 | 19 | 0.050 |
Why?
|
Nephritis | 1 | 2021 | 20 | 0.050 |
Why?
|
Glycine | 1 | 2022 | 156 | 0.050 |
Why?
|
Binding, Competitive | 2 | 2019 | 200 | 0.050 |
Why?
|
Gonadal Steroid Hormones | 1 | 2022 | 124 | 0.050 |
Why?
|
Child, Preschool | 6 | 2021 | 9133 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2021 | 160 | 0.050 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2021 | 21 | 0.050 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2023 | 193 | 0.050 |
Why?
|
Adenosine Triphosphatases | 1 | 2022 | 155 | 0.050 |
Why?
|
Wechsler Scales | 1 | 2021 | 52 | 0.050 |
Why?
|
Stereoisomerism | 1 | 2021 | 91 | 0.050 |
Why?
|
Albuminuria | 1 | 2022 | 164 | 0.050 |
Why?
|
Transglutaminases | 1 | 2022 | 144 | 0.050 |
Why?
|
Ranitidine | 1 | 2021 | 13 | 0.050 |
Why?
|
Atlases as Topic | 1 | 2021 | 9 | 0.050 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2021 | 129 | 0.050 |
Why?
|
Social Problems | 1 | 2021 | 11 | 0.050 |
Why?
|
Transplantation, Homologous | 4 | 2011 | 397 | 0.050 |
Why?
|
Oncogenes | 1 | 2021 | 104 | 0.050 |
Why?
|
Membrane Microdomains | 1 | 2021 | 32 | 0.050 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2021 | 18 | 0.050 |
Why?
|
Immune Evasion | 1 | 2021 | 47 | 0.050 |
Why?
|
Hypoalbuminemia | 1 | 2021 | 26 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2024 | 362 | 0.050 |
Why?
|
gamma-Glutamyl Hydrolase | 1 | 2020 | 2 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2021 | 78 | 0.050 |
Why?
|
Candidiasis | 1 | 2021 | 58 | 0.050 |
Why?
|
Phenylephrine | 1 | 2021 | 75 | 0.050 |
Why?
|
Arctic Regions | 1 | 2020 | 16 | 0.050 |
Why?
|
Behavior Observation Techniques | 1 | 2020 | 9 | 0.050 |
Why?
|
Glucose-6-Phosphatase | 1 | 2020 | 31 | 0.050 |
Why?
|
Vasodilator Agents | 1 | 2023 | 308 | 0.050 |
Why?
|
Granulocytes | 1 | 2021 | 78 | 0.050 |
Why?
|
Erucic Acids | 1 | 2020 | 2 | 0.050 |
Why?
|
Access to Information | 1 | 2021 | 50 | 0.050 |
Why?
|
Immunity | 1 | 2021 | 124 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2021 | 105 | 0.050 |
Why?
|
Serum Response Factor | 1 | 2021 | 27 | 0.050 |
Why?
|
Presenilin-1 | 1 | 2020 | 27 | 0.050 |
Why?
|
Linoleic Acid | 1 | 2021 | 38 | 0.050 |
Why?
|
Ovary | 1 | 1982 | 190 | 0.050 |
Why?
|
Spatial Memory | 1 | 2020 | 17 | 0.050 |
Why?
|
Hematologic Tests | 1 | 2020 | 22 | 0.050 |
Why?
|
Muscle Strength | 1 | 2023 | 275 | 0.050 |
Why?
|
Point Mutation | 1 | 2021 | 217 | 0.050 |
Why?
|
Psoriasis | 1 | 2021 | 75 | 0.050 |
Why?
|
Action Potentials | 1 | 2023 | 410 | 0.050 |
Why?
|
Intercellular Junctions | 1 | 2020 | 34 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2021 | 140 | 0.050 |
Why?
|
Bacteriophage lambda | 1 | 2021 | 81 | 0.050 |
Why?
|
Sarcomeres | 1 | 2021 | 89 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 301 | 0.050 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2020 | 70 | 0.050 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2020 | 54 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 501 | 0.050 |
Why?
|
Ferritins | 1 | 2020 | 57 | 0.050 |
Why?
|
Platelet Aggregation | 1 | 2021 | 94 | 0.050 |
Why?
|
Lipogenesis | 1 | 2021 | 57 | 0.050 |
Why?
|
Coculture Techniques | 1 | 2021 | 202 | 0.050 |
Why?
|
Blotting, Western | 2 | 2014 | 1153 | 0.050 |
Why?
|
Intelligence | 1 | 2021 | 132 | 0.050 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 302 | 0.050 |
Why?
|
Biomimetic Materials | 1 | 2021 | 64 | 0.050 |
Why?
|
Data Mining | 1 | 2021 | 100 | 0.040 |
Why?
|
Fat Body | 1 | 2020 | 4 | 0.040 |
Why?
|
Astrocytes | 1 | 2022 | 163 | 0.040 |
Why?
|
Mitochondria, Liver | 1 | 2020 | 66 | 0.040 |
Why?
|
Cochlea | 1 | 2021 | 90 | 0.040 |
Why?
|
Patient Selection | 3 | 2015 | 654 | 0.040 |
Why?
|
Nootropic Agents | 1 | 2020 | 26 | 0.040 |
Why?
|
Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 25 | 0.040 |
Why?
|
Cytochrome P450 Family 2 | 1 | 2020 | 11 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 212 | 0.040 |
Why?
|
Drug Therapy | 1 | 2020 | 78 | 0.040 |
Why?
|
Permeability | 1 | 2020 | 150 | 0.040 |
Why?
|
Exome | 1 | 2021 | 202 | 0.040 |
Why?
|
Niacinamide | 1 | 2020 | 65 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2021 | 181 | 0.040 |
Why?
|
Protein Domains | 1 | 2021 | 209 | 0.040 |
Why?
|
Phylogeny | 1 | 2023 | 805 | 0.040 |
Why?
|
Object Attachment | 1 | 2020 | 33 | 0.040 |
Why?
|
MCF-7 Cells | 1 | 2020 | 105 | 0.040 |
Why?
|
BRCA1 Protein | 1 | 2020 | 57 | 0.040 |
Why?
|
Quinolinic Acid | 1 | 2019 | 7 | 0.040 |
Why?
|
Protein Stability | 1 | 2020 | 162 | 0.040 |
Why?
|
Hormone Replacement Therapy | 1 | 2020 | 77 | 0.040 |
Why?
|
Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 31 | 0.040 |
Why?
|
Mice, Inbred Strains | 1 | 2020 | 399 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 4 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2001 | 224 | 0.040 |
Why?
|
Doxorubicin | 1 | 2021 | 290 | 0.040 |
Why?
|
Biosynthetic Pathways | 1 | 2019 | 19 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2001 | 238 | 0.040 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2019 | 45 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2021 | 184 | 0.040 |
Why?
|
Gene Deletion | 1 | 2021 | 355 | 0.040 |
Why?
|
DNA Damage | 1 | 2022 | 357 | 0.040 |
Why?
|
Megakaryocytes | 1 | 2019 | 30 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 2021 | 169 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2004 | 577 | 0.040 |
Why?
|
Carbocyanines | 1 | 2019 | 30 | 0.040 |
Why?
|
Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2019 | 5 | 0.040 |
Why?
|
Alanine | 1 | 2019 | 103 | 0.040 |
Why?
|
Wisconsin | 2 | 2001 | 91 | 0.040 |
Why?
|
Blood Vessels | 1 | 2021 | 181 | 0.040 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2019 | 20 | 0.040 |
Why?
|
Blood Transfusion, Autologous | 1 | 2019 | 19 | 0.040 |
Why?
|
Immunotherapy | 1 | 2023 | 479 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2020 | 135 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2018 | 8 | 0.040 |
Why?
|
ATP Binding Cassette Transporter 1 | 1 | 2018 | 10 | 0.040 |
Why?
|
Technetium | 1 | 2019 | 22 | 0.040 |
Why?
|
Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
|
Receptor, ErbB-2 | 1 | 2021 | 302 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 180 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 128 | 0.040 |
Why?
|
3' Flanking Region | 1 | 2018 | 7 | 0.040 |
Why?
|
Administration, Intravenous | 1 | 2019 | 126 | 0.040 |
Why?
|
Tricarboxylic Acids | 1 | 2018 | 10 | 0.040 |
Why?
|
Water | 1 | 2022 | 412 | 0.040 |
Why?
|
Hindlimb | 1 | 2019 | 125 | 0.040 |
Why?
|
Ketoglutaric Acids | 1 | 2018 | 15 | 0.040 |
Why?
|
Alleles | 1 | 2021 | 794 | 0.040 |
Why?
|
Myocardial Contraction | 1 | 2000 | 316 | 0.040 |
Why?
|
Terpenes | 1 | 2018 | 21 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 187 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2018 | 69 | 0.040 |
Why?
|
Germ-Free Life | 1 | 2018 | 30 | 0.040 |
Why?
|
Aerobiosis | 1 | 2018 | 20 | 0.040 |
Why?
|
Maternal Age | 1 | 2019 | 117 | 0.040 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
|
Vaccinia | 1 | 2018 | 18 | 0.040 |
Why?
|
Macaca | 1 | 2018 | 51 | 0.040 |
Why?
|
Sulfhydryl Compounds | 1 | 2020 | 178 | 0.040 |
Why?
|
Ataxia Telangiectasia | 1 | 2018 | 17 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2018 | 78 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2019 | 81 | 0.040 |
Why?
|
Transcriptional Elongation Factors | 1 | 2018 | 33 | 0.040 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2019 | 82 | 0.040 |
Why?
|
Fatty Acids, Volatile | 1 | 2018 | 47 | 0.040 |
Why?
|
Ligands | 1 | 2020 | 569 | 0.040 |
Why?
|
Flavin-Adenine Dinucleotide | 1 | 2018 | 14 | 0.040 |
Why?
|
Gluconeogenesis | 1 | 2018 | 60 | 0.040 |
Why?
|
Transplantation, Heterologous | 1 | 2018 | 187 | 0.040 |
Why?
|
Thioredoxins | 1 | 2018 | 33 | 0.040 |
Why?
|
Caspases, Initiator | 1 | 2018 | 18 | 0.040 |
Why?
|
Stem Cell Niche | 1 | 2018 | 43 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2024 | 573 | 0.040 |
Why?
|
Liver X Receptors | 1 | 2018 | 30 | 0.040 |
Why?
|
Inpatients | 1 | 2022 | 380 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2019 | 489 | 0.040 |
Why?
|
Ovalbumin | 1 | 2018 | 166 | 0.040 |
Why?
|
Trans-Activators | 1 | 2021 | 370 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2021 | 342 | 0.040 |
Why?
|
Purine Nucleotides | 1 | 2018 | 11 | 0.040 |
Why?
|
Interleukin-15 | 1 | 2018 | 76 | 0.040 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 296 | 0.040 |
Why?
|
Thermodynamics | 1 | 2020 | 388 | 0.040 |
Why?
|
Ethanol | 1 | 2002 | 548 | 0.040 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2017 | 14 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 171 | 0.040 |
Why?
|
Dopamine | 1 | 2020 | 237 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2001 | 414 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2019 | 6417 | 0.040 |
Why?
|
Methods | 1 | 2017 | 58 | 0.040 |
Why?
|
Lim Kinases | 1 | 2017 | 5 | 0.040 |
Why?
|
Chemokine CCL5 | 1 | 2017 | 46 | 0.040 |
Why?
|
Smad5 Protein | 1 | 2017 | 7 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2010 | 746 | 0.040 |
Why?
|
Smad1 Protein | 1 | 2017 | 18 | 0.040 |
Why?
|
Naphthoquinones | 1 | 2017 | 17 | 0.040 |
Why?
|
Glycogen Phosphorylase | 1 | 2017 | 4 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 815 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 111 | 0.040 |
Why?
|
Prenatal Care | 1 | 2020 | 257 | 0.040 |
Why?
|
Logistic Models | 1 | 2022 | 1856 | 0.040 |
Why?
|
RNA, Long Noncoding | 1 | 2020 | 157 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 863 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2017 | 64 | 0.040 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 48 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2020 | 386 | 0.040 |
Why?
|
Symporters | 1 | 2017 | 52 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2018 | 202 | 0.040 |
Why?
|
Urinary Tract Infections | 1 | 2019 | 136 | 0.040 |
Why?
|
Pyrroles | 1 | 2018 | 185 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2020 | 472 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2017 | 34 | 0.040 |
Why?
|
Cytosol | 1 | 2018 | 209 | 0.040 |
Why?
|
Models, Genetic | 1 | 2020 | 570 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2021 | 440 | 0.040 |
Why?
|
Transfusion Reaction | 1 | 2017 | 66 | 0.040 |
Why?
|
Microcirculation | 1 | 2017 | 138 | 0.040 |
Why?
|
Receptors, Purinergic P1 | 1 | 2017 | 23 | 0.040 |
Why?
|
Rotarod Performance Test | 1 | 2017 | 17 | 0.040 |
Why?
|
Protein Multimerization | 1 | 2018 | 160 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2016 | 4440 | 0.040 |
Why?
|
Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
|
Chemotaxis | 1 | 2017 | 132 | 0.040 |
Why?
|
Solubility | 1 | 2017 | 226 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2018 | 206 | 0.040 |
Why?
|
Drug Combinations | 2 | 2011 | 289 | 0.040 |
Why?
|
Dysbiosis | 1 | 2018 | 146 | 0.040 |
Why?
|
Attention | 1 | 2020 | 394 | 0.040 |
Why?
|
Weaning | 1 | 2016 | 48 | 0.040 |
Why?
|
Chromatography, Affinity | 1 | 2017 | 83 | 0.040 |
Why?
|
Drug Overdose | 1 | 2021 | 296 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2022 | 739 | 0.030 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 5 | 0.030 |
Why?
|
Hydrazines | 1 | 2016 | 28 | 0.030 |
Why?
|
HeLa Cells | 1 | 2018 | 567 | 0.030 |
Why?
|
Interleukins | 1 | 2018 | 238 | 0.030 |
Why?
|
Bronchioles | 1 | 2016 | 22 | 0.030 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 2016 | 8 | 0.030 |
Why?
|
Deoxyglucose | 1 | 2016 | 43 | 0.030 |
Why?
|
Tacrolimus | 1 | 1997 | 143 | 0.030 |
Why?
|
Myoblasts | 1 | 2017 | 74 | 0.030 |
Why?
|
Interleukin-18 | 1 | 2018 | 222 | 0.030 |
Why?
|
Hospitals, High-Volume | 1 | 2016 | 39 | 0.030 |
Why?
|
Fetal Hemoglobin | 1 | 2016 | 6 | 0.030 |
Why?
|
Triglycerides | 1 | 2018 | 473 | 0.030 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2016 | 59 | 0.030 |
Why?
|
Electron Transport Complex I | 1 | 2016 | 33 | 0.030 |
Why?
|
Adventitia | 1 | 2016 | 37 | 0.030 |
Why?
|
Cell Cycle Checkpoints | 1 | 2016 | 84 | 0.030 |
Why?
|
Indoles | 1 | 2018 | 309 | 0.030 |
Why?
|
Echocardiography | 1 | 2019 | 558 | 0.030 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 131 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2016 | 56 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2016 | 141 | 0.030 |
Why?
|
Neuroendocrine Tumors | 1 | 1997 | 83 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2017 | 187 | 0.030 |
Why?
|
Pyrimidines | 1 | 2019 | 376 | 0.030 |
Why?
|
Tumor Burden | 1 | 2017 | 261 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2016 | 271 | 0.030 |
Why?
|
Blood Viscosity | 1 | 2015 | 17 | 0.030 |
Why?
|
Donor Selection | 1 | 2016 | 73 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2018 | 235 | 0.030 |
Why?
|
Workflow | 1 | 2017 | 136 | 0.030 |
Why?
|
Drainage | 2 | 1993 | 151 | 0.030 |
Why?
|
ErbB Receptors | 1 | 2019 | 557 | 0.030 |
Why?
|
Bison | 1 | 2015 | 6 | 0.030 |
Why?
|
Cholangiocarcinoma | 1 | 1995 | 38 | 0.030 |
Why?
|
Adenosine Diphosphate | 1 | 2015 | 81 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2015 | 141 | 0.030 |
Why?
|
Sirolimus | 1 | 2016 | 192 | 0.030 |
Why?
|
Blood Circulation | 1 | 2015 | 35 | 0.030 |
Why?
|
Bronchoalveolar Lavage | 1 | 2015 | 89 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2019 | 430 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 323 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2019 | 781 | 0.030 |
Why?
|
Calcium Signaling | 1 | 2017 | 211 | 0.030 |
Why?
|
X-Rays | 1 | 2014 | 31 | 0.030 |
Why?
|
Heart | 1 | 2019 | 608 | 0.030 |
Why?
|
Genetic Markers | 1 | 2016 | 325 | 0.030 |
Why?
|
Allergens | 1 | 2018 | 418 | 0.030 |
Why?
|
Glycosylation | 1 | 2015 | 133 | 0.030 |
Why?
|
Physical Conditioning, Animal | 1 | 2017 | 191 | 0.030 |
Why?
|
Thoracotomy | 1 | 2015 | 67 | 0.030 |
Why?
|
Elasticity | 1 | 2015 | 194 | 0.030 |
Why?
|
Postoperative Care | 2 | 1993 | 222 | 0.030 |
Why?
|
Portasystemic Shunt, Surgical | 1 | 1994 | 7 | 0.030 |
Why?
|
Body Size | 1 | 2015 | 92 | 0.030 |
Why?
|
Autoimmunity | 1 | 2020 | 822 | 0.030 |
Why?
|
Cholangitis, Sclerosing | 1 | 1995 | 74 | 0.030 |
Why?
|
Hyperglycemia | 1 | 2018 | 294 | 0.030 |
Why?
|
Microscopy, Electrochemical, Scanning | 1 | 2014 | 1 | 0.030 |
Why?
|
Transfection | 1 | 2017 | 866 | 0.030 |
Why?
|
Arsenites | 1 | 2014 | 4 | 0.030 |
Why?
|
F-Box-WD Repeat-Containing Protein 7 | 1 | 2014 | 6 | 0.030 |
Why?
|
Fetal Growth Retardation | 1 | 2019 | 466 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 1122 | 0.030 |
Why?
|
Furocoumarins | 1 | 2014 | 8 | 0.030 |
Why?
|
Genotype | 1 | 2019 | 1786 | 0.030 |
Why?
|
Homozygote | 1 | 2014 | 186 | 0.030 |
Why?
|
Tranexamic Acid | 1 | 2015 | 40 | 0.030 |
Why?
|
Skull | 1 | 2015 | 117 | 0.030 |
Why?
|
Biopsy | 1 | 2018 | 1056 | 0.030 |
Why?
|
Exercise Test | 1 | 2017 | 539 | 0.030 |
Why?
|
Postpartum Period | 1 | 2016 | 281 | 0.030 |
Why?
|
F-Box Proteins | 1 | 2014 | 20 | 0.030 |
Why?
|
Hospitals, University | 1 | 1994 | 172 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 445 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2016 | 314 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2014 | 177 | 0.030 |
Why?
|
Hypertension, Portal | 1 | 1994 | 62 | 0.030 |
Why?
|
Serine | 1 | 2014 | 125 | 0.030 |
Why?
|
Aldosterone | 1 | 2014 | 42 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2015 | 189 | 0.030 |
Why?
|
Adiposity | 1 | 2018 | 468 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 398 | 0.030 |
Why?
|
Down-Regulation | 1 | 2016 | 601 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 528 | 0.030 |
Why?
|
Hemostasis | 1 | 2014 | 67 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 962 | 0.030 |
Why?
|
Isoelectric Focusing | 1 | 2013 | 34 | 0.030 |
Why?
|
Urologic Diseases | 1 | 1993 | 36 | 0.030 |
Why?
|
Photochemistry | 1 | 2014 | 125 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1996 | 221 | 0.030 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1993 | 18 | 0.030 |
Why?
|
Registries | 2 | 2016 | 1770 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 139 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2017 | 386 | 0.030 |
Why?
|
Keratinocytes | 1 | 2014 | 215 | 0.030 |
Why?
|
Tissue Preservation | 1 | 1992 | 13 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 1216 | 0.030 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2012 | 45 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 1057 | 0.030 |
Why?
|
Technology, Pharmaceutical | 1 | 2012 | 19 | 0.030 |
Why?
|
Ferric Compounds | 1 | 2012 | 40 | 0.030 |
Why?
|
Hospitalization | 1 | 2021 | 1765 | 0.030 |
Why?
|
Pneumonia | 1 | 2017 | 576 | 0.030 |
Why?
|
Drug Contamination | 1 | 2012 | 53 | 0.030 |
Why?
|
Dithiothreitol | 1 | 2011 | 17 | 0.020 |
Why?
|
Molecular Weight | 1 | 2012 | 329 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 1994 | 548 | 0.020 |
Why?
|
von Willebrand Factor | 1 | 2011 | 56 | 0.020 |
Why?
|
Survival Rate | 4 | 1999 | 1650 | 0.020 |
Why?
|
Atracurium | 1 | 1991 | 13 | 0.020 |
Why?
|
Family | 1 | 1995 | 594 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 1995 | 289 | 0.020 |
Why?
|
Complement C4b | 1 | 2011 | 9 | 0.020 |
Why?
|
Dystrophin | 1 | 2011 | 30 | 0.020 |
Why?
|
Conalbumin | 1 | 1990 | 3 | 0.020 |
Why?
|
Hemophilia A | 1 | 2011 | 70 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2011 | 102 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 1993 | 352 | 0.020 |
Why?
|
Quadriceps Muscle | 1 | 2011 | 100 | 0.020 |
Why?
|
Neuromuscular Diseases | 1 | 1991 | 90 | 0.020 |
Why?
|
Urinary Bladder | 1 | 1991 | 165 | 0.020 |
Why?
|
Cyclosporins | 1 | 1989 | 59 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2008 | 87 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2008 | 105 | 0.020 |
Why?
|
Incidence | 3 | 2001 | 2335 | 0.020 |
Why?
|
Nephrectomy | 2 | 1998 | 150 | 0.020 |
Why?
|
Recurrence | 1 | 2008 | 952 | 0.020 |
Why?
|
Cytochromes c | 1 | 2004 | 62 | 0.010 |
Why?
|
KB Cells | 1 | 2003 | 4 | 0.010 |
Why?
|
Caspase 3 | 1 | 2004 | 237 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 147 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 165 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 2002 | 116 | 0.010 |
Why?
|
Leucine | 1 | 1982 | 108 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 277 | 0.010 |
Why?
|
Cysts | 1 | 2002 | 93 | 0.010 |
Why?
|
Oocytes | 1 | 1982 | 171 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2003 | 275 | 0.010 |
Why?
|
Cell Division | 1 | 2003 | 759 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2001 | 183 | 0.010 |
Why?
|
Probability | 1 | 2001 | 294 | 0.010 |
Why?
|
Age Factors | 2 | 1999 | 2907 | 0.010 |
Why?
|
Muromonab-CD3 | 1 | 1998 | 23 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2001 | 1087 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2001 | 1178 | 0.010 |
Why?
|
Mycophenolic Acid | 1 | 1998 | 81 | 0.010 |
Why?
|
Cause of Death | 1 | 2000 | 368 | 0.010 |
Why?
|
Perfusion | 1 | 1998 | 150 | 0.010 |
Why?
|
Bile | 1 | 1997 | 26 | 0.010 |
Why?
|
Pancreas | 1 | 1999 | 280 | 0.010 |
Why?
|
Potassium | 1 | 1997 | 128 | 0.010 |
Why?
|
Sodium | 1 | 1997 | 183 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 169 | 0.010 |
Why?
|
Splenectomy | 1 | 1996 | 54 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 1996 | 115 | 0.010 |
Why?
|
Diabetic Nephropathies | 2 | 1989 | 234 | 0.010 |
Why?
|
Colectomy | 1 | 1995 | 87 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1997 | 390 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1998 | 666 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 1995 | 222 | 0.010 |
Why?
|
Renal Dialysis | 1 | 1996 | 369 | 0.010 |
Why?
|
Employment | 1 | 1993 | 139 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 1991 | 39 | 0.010 |
Why?
|
Thyroidectomy | 1 | 1991 | 52 | 0.010 |
Why?
|
Chick Embryo | 1 | 1990 | 122 | 0.010 |
Why?
|
Preoperative Care | 1 | 1991 | 318 | 0.010 |
Why?
|
Attitude to Health | 1 | 1993 | 409 | 0.010 |
Why?
|
Heart Diseases | 1 | 1989 | 330 | 0.000 |
Why?
|